Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal protein binding	GPHN KATNAL2 SHROOM3 SPATA31A3 MAP7D3 ANK3 MAP4 MYO6 IFT74 SPTBN2 TOM1 LRRC10 PANX1 ACTN3 KATNAL1 NEB SHROOM2 SPAG5 CCDC88C DES CLIP3 DST NF1 FHOD1 VASH2 DMD VCL MX2	1.09e-06	1099	185	28	GO:0008092
GeneOntologyMolecularFunction	retinoic acid-responsive element binding	ZNF536 RXRB RXRG	2.66e-05	7	185	3	GO:0044323
GeneOntologyMolecularFunction	ATP-dependent activity	DNAH3 KATNAL2 ABCA1 MYO6 VPS4B PSMC1 RNF213 KATNAL1 ATP13A2 DNAH14 BPTF ATP6V1H MTREX CDC6 ATP2B3 SNRNP200 ATP2B4	6.02e-05	614	185	17	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	DNAH3 KATNAL2 ABCA1 VPS4B PSMC1 RNF213 KATNAL1 ATP13A2 ATP6V1H MTREX CDC6 ATP2B3 SNRNP200 ATP2B4	6.59e-05	441	185	14	GO:0016887
GeneOntologyMolecularFunction	[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity	HS3ST3B1 HS3ST3A1	8.54e-05	2	185	2	GO:0033872
GeneOntologyMolecularFunction	microtubule binding	KATNAL2 MAP7D3 MAP4 KATNAL1 SPAG5 CCDC88C CLIP3 DST NF1 VASH2 MX2	1.47e-04	308	185	11	GO:0008017
GeneOntologyMolecularFunction	actin binding	SHROOM3 SPATA31A3 MYO6 SPTBN2 LRRC10 PANX1 ACTN3 NEB SHROOM2 DST FHOD1 VASH2 DMD VCL	1.57e-04	479	185	14	GO:0003779
GeneOntologyMolecularFunction	zinc ion binding	DDAH1 EARS2 KDM5A POLR2A CUL9 ZNF318 NR3C1 ATP13A2 RXRB RXRG ZCCHC14 POLR3B L3MBTL1 ZFHX4 CTCF PAM PHF14 ALAD DMD ST18	2.36e-04	891	185	20	GO:0008270
GeneOntologyMolecularFunction	actin filament binding	SHROOM3 MYO6 SPTBN2 PANX1 ACTN3 NEB SHROOM2 FHOD1 VCL	2.76e-04	227	185	9	GO:0051015
GeneOntologyMolecularFunction	tubulin binding	KATNAL2 MAP7D3 MAP4 IFT74 KATNAL1 SPAG5 CCDC88C CLIP3 DST NF1 VASH2 MX2	6.70e-04	428	185	12	GO:0015631
GeneOntologyCellularComponent	Z disc	ANK3 ACTN3 NEB DES DST PRKD1 DMD ATP2B4 VCL AHNAK2	1.03e-06	151	186	10	GO:0030018
GeneOntologyCellularComponent	I band	ANK3 ACTN3 NEB DES DST PRKD1 DMD ATP2B4 VCL AHNAK2	2.45e-06	166	186	10	GO:0031674
GeneOntologyCellularComponent	sarcomere	ANK3 LRRC10 ACTN3 NEB DES DST PRKD1 DMD ATP2B4 VCL AHNAK2	1.50e-05	249	186	11	GO:0030017
GeneOntologyCellularComponent	myofibril	ANK3 LRRC10 ACTN3 NEB DES DST PRKD1 DMD ATP2B4 VCL AHNAK2	3.51e-05	273	186	11	GO:0030016
GeneOntologyCellularComponent	costamere	ANK3 DMD VCL AHNAK2	3.92e-05	22	186	4	GO:0043034
GeneOntologyCellularComponent	contractile muscle fiber	ANK3 LRRC10 ACTN3 NEB DES DST PRKD1 DMD ATP2B4 VCL AHNAK2	6.06e-05	290	186	11	GO:0043292
GeneOntologyCellularComponent	supramolecular fiber	DNAH3 KATNAL2 SHROOM3 ANK3 MAP4 MYO6 LRRC10 AKNA ACTN3 KATNAL1 NEB SHROOM2 DNAH14 SPAG5 DES CLIP3 DST IFFO2 PRKD1 DMD ATP2B4 VCL MX2 AHNAK2	1.32e-04	1179	186	24	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	DNAH3 KATNAL2 SHROOM3 ANK3 MAP4 MYO6 LRRC10 AKNA ACTN3 KATNAL1 NEB SHROOM2 DNAH14 SPAG5 DES CLIP3 DST IFFO2 PRKD1 DMD ATP2B4 VCL MX2 AHNAK2	1.46e-04	1187	186	24	GO:0099081
GeneOntologyCellularComponent	sarcolemma	ANK3 SLC38A2 DES DST DMD ATP2B4 VCL AHNAK2	3.10e-04	190	186	8	GO:0042383
GeneOntologyCellularComponent	intercalated disc	ANK3 DES DST FHOD1 VCL	3.50e-04	68	186	5	GO:0014704
GeneOntologyCellularComponent	cell cortex	SHROOM3 MYO6 SPTBN2 SH3BP1 ACTN3 ARFIP2 SHROOM2 ITPR2 CLIP3 DST PRKD1	5.11e-04	371	186	11	GO:0005938
GeneOntologyCellularComponent	presynaptic endocytic zone	MYO6 ITSN1 SNAP91	5.13e-04	18	186	3	GO:0098833
GeneOntologyCellularComponent	katanin complex	KATNAL2 KATNAL1	7.74e-04	5	186	2	GO:0008352
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	DNAH3 KATNAL2 SHROOM3 MAP4 MYO6 AKNA ACTN3 KATNAL1 SHROOM2 DNAH14 SPAG5 DES CLIP3 DST IFFO2 DMD VCL MX2	1.14e-03	899	186	18	GO:0099513
GeneOntologyCellularComponent	type III intermediate filament	DES DST	1.15e-03	6	186	2	GO:0045098
GeneOntologyCellularComponent	somatodendritic compartment	GPHN TANC2 SCN11A ANK3 MYO6 ITSN1 SPTBN2 NR3C1 TMEM222 SHROOM2 ATP13A2 SYT7 SLC38A2 BPTF KIRREL3 NF1 SNAP91 VPS13A PAM GNAT1 DMD SEZ6L	1.39e-03	1228	186	22	GO:0036477
GeneOntologyCellularComponent	cell-cell contact zone	ANK3 DES DST FHOD1 VCL	1.53e-03	94	186	5	GO:0044291
GeneOntologyCellularComponent	postsynaptic cytoskeleton	MYO6 ITSN1 SPTBN2	1.55e-03	26	186	3	GO:0099571
GeneOntologyCellularComponent	microtubule plus-end	SPAG5 CLIP3 DST	1.93e-03	28	186	3	GO:0035371
Domain	AAA	DNAH3 KATNAL2 ABCA1 VPS4B PSMC1 RNF213 KATNAL1 CDC6 SNRNP200	1.25e-05	144	183	9	SM00382
Domain	AAA+_ATPase	DNAH3 KATNAL2 ABCA1 VPS4B PSMC1 RNF213 KATNAL1 CDC6 SNRNP200	1.25e-05	144	183	9	IPR003593
Domain	Spectrin	SPTBN2 ACTN3 DST DMD	6.83e-05	23	183	4	PF00435
Domain	ACTININ_2	SPTBN2 ACTN3 DST DMD	6.83e-05	23	183	4	PS00020
Domain	ACTININ_1	SPTBN2 ACTN3 DST DMD	6.83e-05	23	183	4	PS00019
Domain	Actinin_actin-bd_CS	SPTBN2 ACTN3 DST DMD	6.83e-05	23	183	4	IPR001589
Domain	ARM-type_fold	PPP4R1 USP24 CUL9 WDFY4 ITPR2 DOCK5 RIF1 ATP6V1H NF1 FHOD1 MROH7 HECTD1	1.34e-04	339	183	12	IPR016024
Domain	AAA	KATNAL2 VPS4B PSMC1 KATNAL1 CDC6	1.53e-04	52	183	5	PF00004
Domain	Spectrin_repeat	SPTBN2 ACTN3 DST DMD	1.75e-04	29	183	4	IPR002017
Domain	ATPase_AAA_core	KATNAL2 VPS4B PSMC1 KATNAL1 CDC6	1.83e-04	54	183	5	IPR003959
Domain	SPEC	SPTBN2 ACTN3 DST DMD	2.59e-04	32	183	4	SM00150
Domain	Spectrin/alpha-actinin	SPTBN2 ACTN3 DST DMD	2.59e-04	32	183	4	IPR018159
Domain	Teashirt_fam	TSHZ2 TSHZ1	2.85e-04	3	183	2	IPR027008
Domain	ASD1	SHROOM3 SHROOM2	2.85e-04	3	183	2	PF08688
Domain	ASD1_dom	SHROOM3 SHROOM2	2.85e-04	3	183	2	IPR014800
Domain	ASD1	SHROOM3 SHROOM2	2.85e-04	3	183	2	PS51306
Domain	-	PPP4R1 CUL9 WDFY4 RIF1 ATP6V1H NF1 FHOD1 MROH7 HECTD1	3.51e-04	222	183	9	1.25.10.10
Domain	ATP_Ca_trans_C	ATP2B3 ATP2B4	5.66e-04	4	183	2	IPR022141
Domain	ATP_Ca_trans_C	ATP2B3 ATP2B4	5.66e-04	4	183	2	PF12424
Domain	Shroom_fam	SHROOM3 SHROOM2	5.66e-04	4	183	2	IPR027685
Domain	ASD2_dom	SHROOM3 SHROOM2	5.66e-04	4	183	2	IPR014799
Domain	ASD2	SHROOM3 SHROOM2	5.66e-04	4	183	2	PF08687
Domain	ASD2	SHROOM3 SHROOM2	5.66e-04	4	183	2	PS51307
Domain	P-type_ATPase_IIB	ATP2B3 ATP2B4	5.66e-04	4	183	2	IPR006408
Domain	Cation_ATPase_N	ATP13A2 ATP2B3 ATP2B4	6.78e-04	18	183	3	SM00831
Domain	ATPase_P-typ_cation-transptr_N	ATP13A2 ATP2B3 ATP2B4	7.99e-04	19	183	3	IPR004014
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	TANC2 ZNF536 PDE6A MAP7D3 ACADSB MYO6 NACC1 USP24 LRRC10 MUC16 NR3C1 NEB GTF3C5 SLC38A2 NBPF15 NF1 VPS13A FGD5 CNOT1 ATP2B3 ZNF687 AHNAK2	7.60e-12	638	189	22	31182584
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	GPHN FOXO3B ZNF536 MAP7D3 KDM5A NACC1 IFT74 POLR2A COPB2 CUL9 NR3C1 GTF3C5 RXRB BPTF DES RIF1 METTL13 ZFHX4 SUGP2 HNRNPUL2 SUDS3 TSHZ1 ATP2B3 SNRNP200	5.97e-11	857	189	24	25609649
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TANC2 TDRKH ZNF536 BRPF3 EARS2 KDM5A NACC1 POLR2A CUL9 RNF213 ZNF318 POLR1G SYT7 BPTF METTL13 MCTP1 SMG7 ZFHX4 SUGP2 CTCF ZNF592 SUDS3 TAF1 FKBP8 CLSPN ZNF687 SEZ6L	9.18e-11	1116	189	27	31753913
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	DNAH3 SGSM1 PCDHGB3 NACC1 ITSN1 POLR2A SPTBN2 COPB2 PSMC1 RNF213 GPRIN1 DNAH14 ITPR2 SFXN1 DOCK5 DST ZNF592 VPS13A MAP3K9 PHF14 CNOT1 SNRNP200	1.17e-10	736	189	22	29676528
Pubmed	Human transcription factor protein interaction networks.	SOX5 ZNF536 MYO6 KDM5A NACC1 COPB2 PSMC1 CUL9 ZNF318 ECH1 SFXN1 BPTF RIF1 DST SMG7 ZFHX4 SUGP2 HNRNPUL2 CTCF ZNF592 PABPN1 SUDS3 PITX1 CSTF1 ELAVL1 TAF1 USP27X CNOT1 VCL ZNF687	2.28e-10	1429	189	30	35140242
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	GPHN TANC2 DDAH1 ANK3 MAP4 MYO6 ITSN1 SPTBN2 TOM1 COPB2 PSMC1 ACTN3 IDH2 SHROOM2 ITPR2 ATP6V1H DST NF1 SUGP2 SNAP91 HNRNPUL2 KIAA1217 VCAN ELAVL1 DMD CNOT1 ATP2B3 SNRNP200 ATP2B4 VCL	2.36e-10	1431	189	30	37142655
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GPHN MAP7D3 MAP4 MYO6 NACC1 POLR2A ZNF318 GLOD4 NR3C1 GPRIN1 ECH1 SPAG5 RIF1 DST SMG7 SUGP2 CTCF KIAA1217 FHOD1 FAM169A HERC4 SNRNP200 VCL AHNAK2	3.38e-10	934	189	24	33916271
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MAP4 POLR2A SPTBN2 COPB2 USP24 CUL9 ZNF318 BPTF RIF1 DST NF1 SUGP2 CTCF SUPT6H ELAVL1 MTREX HECTD1 CNOT1 SNRNP200 VCL	5.69e-10	653	189	20	22586326
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GPHN TANC2 AMPD2 SHROOM3 ANK3 KDM5A NACC1 ITSN1 SPTBN2 HECTD4 SH3BP1 ZNF318 CCDC88C DST NF1 CELSR2 SNAP91 HNRNPUL2 CTCF KIAA1217 ELAVL1 PRKD1 CNOT1 ATP2B4	6.22e-10	963	189	24	28671696
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GPHN MAP7D3 ANK3 MAP4 IFT74 POLR2A SPTBN2 USP24 ZNF318 GPRIN1 GTF3C5 BPTF SMG7 SUGP2 TAF1 CNOT1 SNRNP200 VCL	1.49e-09	549	189	18	38280479
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	TDRKH SHROOM3 MAP7D3 ANK3 MYO6 MUC16 RNF213 ZNF318 ARFIP2 GPRIN1 SFXN1 DOCK5 SLC38A2 RIF1 DST SUGP2 VPS13A IFFO2 FKBP8 CLSPN SNRNP200	1.92e-09	777	189	21	35844135
Pubmed	A protein interaction landscape of breast cancer.	ANK3 MYO6 SPTLC2 POLR2A SPTBN2 TOM1 CUL9 POLR1G SPAG5 ATP6V1H DST HNRNPUL2 CTCF CSTF1 ELAVL1 AP1M1 MTREX EXOSC7 ATP2B4	2.24e-09	634	189	19	34591612
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SLC9A8 SHROOM3 SGSM1 ANK3 MAP4 MYO6 TSHZ2 TOM1 HECTD4 ZDHHC14 RNF213 KATNAL1 ECH1 SHROOM2 DNAH14 SFXN1 DOCK5 BPTF PTPDC1 SMG7 SUGP2 HPCAL1 SUPT6H KIAA1217 PHF14 PRKD1 NRG3 HECTD1 CNOT1	2.59e-09	1489	189	29	28611215
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DIS3L2 MAP4 MYO6 SPTLC2 POLR2A COPB2 PSMC1 POLR1G ECH1 GTF3C5 SFXN1 RIF1 METTL13 POLR3B DST NF1 SUGP2 HNRNPUL2 PABPN1 FHOD1 CSTF1 ELAVL1 AP1M1 MTREX SNRNP200 VCL AHNAK2	5.88e-09	1353	189	27	29467282
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZNF536 KDM5A NACC1 IFT74 VPS4B USP24 ZNF318 GTF3C5 SPAG5 DST ZFHX4 ZNF592 TAF1 CNOT1 ZNF687	1.11e-08	418	189	15	34709266
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	GPHN TANC2 AMPD2 SHROOM3 MAP7D3 MAP4 KDM5A IFT74 ZCCHC14 FSIP2 SLC38A2 CCDC88C DST NF1 KIAA1217 ZNF286B MAP3K9 AP1M1 MTREX HECTD1 AHNAK2	1.15e-08	861	189	21	36931259
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MAP4 NACC1 POLR2A COPB2 RNF213 POLR1G GTF3C5 BPTF RIF1 POLR3B SUGP2 HNRNPUL2 CTCF ZNF592 PABPN1 SUDS3 SUPT6H CSTF1 PHF14 TAF1 MTREX ZNF687	4.02e-08	1014	189	22	32416067
Pubmed	Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway.	ANK3 DES DMD VCL	5.81e-08	8	189	4	28826662
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MAP4 MYO6 POLR2A COPB2 PSMC1 GLOD4 IDH2 GTF3C5 SFXN1 SLC38A2 RIF1 METTL13 ATP6V1H NF1 HNRNPUL2 PABPN1 SUPT6H CSTF1 ELAVL1 AP1M1 FGD5 MTREX CNOT1 ATP2B3 SNRNP200 VCL	6.90e-08	1425	189	26	30948266
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	GPHN TANC2 AMPD2 ANK3 MAP4 COPB2 USP24 PSMC1 IDH2 GPRIN1 SHROOM2 SFXN1 NF1 CELSR2 SUGP2 HNRNPUL2 HPCAL1 KIAA1217 PEX19 FAM169A AP1M1 FKBP8 CNOT1	7.07e-08	1139	189	23	36417873
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TANC2 SLC9A8 MYO6 SPTLC2 SPTBN2 RNF213 WDFY4 CCDC88C METTL13 FAM169A ZNF286B PHF14 HECTD1 SNRNP200 ZNF286A	9.67e-08	493	189	15	15368895
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	TANC2 SHROOM3 COPB2 USP24 PSMC1 RXRB DOCK5 RIF1 METTL13 NF1 PABPN1 FHOD1 ELAVL1 MTREX CNOT1 SNRNP200	1.42e-07	582	189	16	20467437
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PPP4R1 ANK3 MYO6 KDM5A IFT74 ITSN1 SPTBN2 HECTD4 PSMC1 CUL9 MYNN TMEM222 SHROOM2 RXRG POLR3B TXNDC15 DST ZNF592 ALAD TAF1 HECTD1 ST18 SNRNP200 SEZ6L	1.51e-07	1285	189	24	35914814
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	MAP7D3 MAP4 COPB2 POLR1G GTF3C5 SFXN1 BPTF RIF1 POLR3B SUGP2 HNRNPUL2 PABPN1 MTREX CDC6 HECTD1 EXOSC7 CNOT1 SNRNP200	2.05e-07	759	189	18	35915203
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	BRPF3 SHROOM3 EARS2 HECTD4 AKNA SLC38A2 DST SMG7 ZNF592 SUPT6H MTREX EXOSC7 HERC4 CNOT1 ZNF687	2.38e-07	529	189	15	14621295
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	MAP4 KDM5A NACC1 ITSN1 POLR2A USP24 ZNF318 POLR1G GPRIN1 BPTF RIF1 NF1 SUGP2 ZNF592 FHOD1 PHF14 SNRNP200 ZNF687	2.72e-07	774	189	18	15302935
Pubmed	Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN.	MAP4 MYO6 SPTBN2 TOM1 COPB2 PSMC1 IDH2 PAAF1 ELAVL1 PHF14 CNOT1 SNRNP200	3.37e-07	334	189	12	30425250
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	MAP4 IFT74 CCDC168 ZNF318 FSIP2 DST CNOT1 AHNAK2	3.96e-07	123	189	8	26912792
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	ACADSB MYO6 EARS2 SPTLC2 VPS4B POLR2A TOM1 COPB2 PSMC1 GTF3C5 SFXN1 RIF1 METTL13 ATP6V1H PABPN1 CSTF1 ELAVL1 AP1M1 FKBP8 CDC6 HECTD1 CNOT1 SNRNP200	4.01e-07	1257	189	23	37317656
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	ACADSB MAP4 MYO6 IFT74 SPTLC2 PSMC1 GTF3C5 SFXN1 ATP6V1H POLR3B SUPT6H AP1M1 MTREX CNOT1 SNRNP200	4.90e-07	560	189	15	35241646
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	KATNAL2 NACC1 POLR2A POLR1G SFXN1 BPTF RIF1 SUGP2 CTCF ZNF592 PABPN1 SUPT6H ELAVL1 PHF14 MTREX CLSPN USP27X EXOSC7 SNRNP200 VCL	5.24e-07	989	189	20	36424410
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	TANC2 MAP7D3 MYO6 KDM5A POLR2A ZNF318 SPAG5 RIF1 SUPT6H KIAA1217 PITX1 MTREX	7.65e-07	361	189	12	30344098
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	MAP4 POLR2A SPTBN2 PSMC1 ZNF318 GTF3C5 ITPR2 SFXN1 BPTF RIF1 DST NF1 SUGP2 HNRNPUL2 SUPT6H ELAVL1 FKBP8 MTREX CNOT1 SNRNP200	8.96e-07	1024	189	20	24711643
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	IQCF5 SCN11A PDE6A PCDHGB3 KDM5A ITSN1 SPTBN2 MYNN ZNF318 ACTN3 NEB BPTF DES SEPHS2 DST SNAP91 HPCAL1 EFCAB12 VASH2 VPS13A FAM169A PHF14 DMD ATP2B3	1.18e-06	1442	189	24	35575683
Pubmed	K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors.	KATNAL2 SHROOM3 MAP7D3 MYO6 ITSN1 TOM1 PPP2R3B RNF213 ZCCHC14 RIF1 METTL13 TXNDC15 AP1M1 CDC6 HERC4	1.25e-06	604	189	15	38803224
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PPP4R1 ANK3 POLR2A SPTBN2 COPB2 PPP2R3B PSMC1 RNF213 GPRIN1 PAAF1 ITPR2 PTPDC1 RIF1 SMG7 VPS13A PEX19 FKBP8 DMD CNOT1 ATP2B4	1.30e-06	1049	189	20	27880917
Pubmed	The growth factor midkine is modulated by both glucocorticoid and retinoid in fetal lung development.	SFTPC NR3C1 VCAN	1.57e-06	5	189	3	12495930
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	MAP7D3 ANK3 MYO6 ITSN1 ZNF318 SMG7 KIAA1217 CNOT1 ATP2B3 AHNAK2	1.98e-06	263	189	10	34702444
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	ACADSB SPTLC2 POLR2A MUC16 RNF213 RXRB DOCK5 L3MBTL1 SUGP2 VPS13A FGD5 TAF1 USP27X ATP2B4	2.25e-06	552	189	14	10737800
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SOX5 KDM5A ZDHHC14 MYNN ZNF318 NR3C1 GTF3C5 RXRB ZCCHC14 BPTF RIF1 CTCF ZNF592 ZNF286B PHF14 ZNF286A ZNF687	2.31e-06	808	189	17	20412781
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	POLR2A COPB2 USP24 PSMC1 GTF3C5 RIF1 SUGP2 SUPT6H ELAVL1 AP1M1 FKBP8 MTREX HECTD1 CNOT1 SNRNP200	2.45e-06	638	189	15	33239621
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	SHROOM3 ZNF318 RIF1 MCTP1 KIAA1217 DMD	2.54e-06	71	189	6	33541421
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	SOX5 ITSN1 PPP2R3B ECH1 SPAG5 NBPF15 NF1 L3MBTL1 PABPN1 PEX19 ELAVL1 ALAS1 FKBP8 CCDC136	2.66e-06	560	189	14	21653829
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	MYO6 USP24 CUL9 PAAF1 ITPR2 DST SUGP2 SUPT6H HECTD1	2.66e-06	212	189	9	33853758
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TANC2 SHROOM3 POLR2A HECTD4 AKNA CUL9 PANX1 ATP13A2 ITPR2 ZCCHC14 CCDC88C SEPHS2 DST CELSR2 SUGP2 ZNF592 PITX1 HECTD1 ZNF687 AHNAK2	2.84e-06	1105	189	20	35748872
Pubmed	A human MAP kinase interactome.	ANK3 MYO6 ITSN1 SPTBN2 MYNN NEB DES RIF1 DST FHOD1 TAF1 DMD SNRNP200	2.94e-06	486	189	13	20936779
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	TANC2 PPP4R1 NACC1 POLR2A TOM1 COPB2 GTF3C5 DNAAF3 PTPDC1 SMG7 HPCAL1 KIAA1217 PITX1 PEX19 AP1M1 DMD MTREX CLSPN CNOT1	4.35e-06	1038	189	19	26673895
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	SHROOM3 MAP7D3 IFT74 ITSN1 SPTBN2 PSMC1 ARFIP2 ECH1 SPAG5 CCDC88C ATP6V1H SMG7 KIAA1217 IFFO2 EXOSC7 CNOT1 VCL	4.73e-06	853	189	17	28718761
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	MAP4 MYO6 NEB DOCK5 CCDC88C SEPHS2 NBPF15 DST KIAA1217 ELAVL1 HECTD1 SNRNP200 CCDC136	5.27e-06	513	189	13	25798074
Pubmed	The structure of the nuclear hormone receptors.	NR3C1 RXRB RXRG	5.44e-06	7	189	3	10406480
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	POLR2A HECTD4 ZNF318 ITPR2 NF1 HNRNPUL2 ZNF592 SUPT6H MTREX HECTD1 EXOSC7 ZNF687	5.87e-06	440	189	12	34244565
Pubmed	The Deubiquitinase USP37 Regulates Chromosome Cohesion and Mitotic Progression.	ECH1 RIF1 SUGP2 TAF1 MTREX SNRNP200	6.80e-06	84	189	6	26299517
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	KDM5A POLR2A SPTBN2 COPB2 HECTD4 IDH2 GTF3C5 SFXN1 BPTF DST SUGP2 HNRNPUL2 PABPN1 SUPT6H VCAN CSTF1 ELAVL1 CNOT1 SNRNP200	7.84e-06	1082	189	19	38697112
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	MYO6 POLR2A COPB2 PSMC1 IDH2 GTF3C5 SFXN1 METTL13 POLR3B SUGP2 ELAVL1 AP1M1 MTREX CNOT1 SNRNP200	7.99e-06	704	189	15	29955894
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	POLR2A COPB2 RIF1 SUGP2 HNRNPUL2 PABPN1 ELAVL1 MTREX SNRNP200	8.31e-06	244	189	9	29884807
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	MAP7D3 KDM5A POLR2A ZNF318 POLR1G GTF3C5 DOCK5 BPTF RIF1 DST CTCF PABPN1 SUDS3 SUPT6H PITX1 ELAVL1 PHF14 MTREX CDC6 SNRNP200 ZNF687	8.48e-06	1294	189	21	30804502
Pubmed	Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies.	ACTN3 NEB DES	8.67e-06	8	189	3	11309420
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	DNAH3 DIS3L2 MAP4 PSMC1 GLOD4 IDH2 SFXN1 ATP6V1H NF1 HNRNPUL2 PABPN1 ELAVL1 FKBP8 GNAT1 VCL MX2	9.12e-06	803	189	16	36517590
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	POLR2A GTF3C5 RXRG POLR3B HNRNPUL2 SUPT6H ELAVL1 TAF1 MTREX CNOT1 SNRNP200	1.06e-05	390	189	11	17643375
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ZNF536 VPS4B ITSN1 POLR2A RNF213 GTF3C5 ITPR2 ZCCHC14 SLC38A2 POLR3B PEX19 CLSPN HECTD1 VCL ZNF687	1.28e-05	733	189	15	34672954
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	ACADSB USE1 SPTLC2 SPTBN2 TOM1 COPB2 PSMC1 RNF213 IDH2 SPAG5 ITPR2 ATP6V1H POLR3B DST HNRNPUL2 PEX19 ELAVL1 FKBP8 MTREX CNOT1 SNRNP200 AHNAK2	1.31e-05	1440	189	22	30833792
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	SHROOM3 ANK3 MAP4 MYO6 SPTBN2 GLOD4 ARFIP2 GPRIN1 SYT7 DST KIAA1217 ATP2B4 VCL	1.47e-05	565	189	13	25468996
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	GPHN MAP4 POLR2A COPB2 SPAG5 SFXN1 RIF1 PABPN1 SUDS3 SUPT6H ELAVL1 AP1M1 FKBP8 MTREX	1.51e-05	653	189	14	33742100
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	MAP4 POLR2A COPB2 PSMC1 RNF213 BPTF RIF1 TAF1 SNRNP200 AHNAK2	1.53e-05	332	189	10	32786267
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	GPHN PPP4R1 AMPD2 MAP4 POLR2A TOM1 COPB2 USP24 PSMC1 NR3C1 ARFIP2 PAAF1 ATP6V1H HNRNPUL2 AP1M1 ALAD HECTD1 HERC4 CNOT1 SNRNP200 VCL AHNAK2	1.53e-05	1455	189	22	22863883
Pubmed	Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer.	MYO6 TOM1 HECTD4 PSMC1 RNF213 METTL13 KIAA1217 PRKD1 SNRNP200	1.56e-05	264	189	9	32814769
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	AMPD2 MYO6 EARS2 USE1 IFT74 SPTLC2 TOM1 COPB2 USP24 PSMC1 SPAG5 SFXN1 SLC38A2 ATP6V1H FKBP8 HECTD1 ATP2B4	1.70e-05	942	189	17	31073040
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	MAP4 IFT74 POLR2A SPTBN2 USP24 GLOD4 GPRIN1 ECH1 DST SUGP2 VCAN ELAVL1	2.01e-05	498	189	12	36634849
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	POLR2A GTF3C5 CCDC88C RIF1 ZFHX4 CTCF ZNF592 SUDS3 PITX1 CSTF1 TAF1 SNRNP200 ZNF687	2.04e-05	583	189	13	29844126
Pubmed	Systematic proteomics of the VCP-UBXD adaptor network identifies a role for UBXN10 in regulating ciliogenesis.	ACADSB MYO6 IFT74 ATP6V1H VPS13A PEX19 CSTF1 ATP2B3	2.04e-05	209	189	8	26389662
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	TDRKH MAP7D3 ACADSB MYO6 EARS2 USE1 PSMC1 RNF213 IDH2 ECH1 ITPR2 DST HNRNPUL2 KIAA1217 VPS13A PEX19 FAM169A ELAVL1 ALAS1 MALSU1 FKBP8 AHNAK2	2.34e-05	1496	189	22	32877691
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	TDRKH KATNAL2 SHROOM3 MAP4 KDM5A POLR2A TOM1 PSMC1 ZNF318 POLR1G SYT7 RIF1 DST CTCF ZNF592 SUPT6H CSTF1 PHF14 FKBP8 MTREX EXOSC7 ZNF687	2.36e-05	1497	189	22	31527615
Pubmed	Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy.	ACTN3 DMD	2.94e-05	2	189	2	28139640
Pubmed	Adaptor Protein-1 Complex Affects the Endocytic Trafficking and Function of Peptidylglycine α-Amidating Monooxygenase, a Luminal Cuproenzyme.	PAM AP1M1	2.94e-05	2	189	2	26170456
Pubmed	Nuclear myosin VI enhances RNA polymerase II-dependent transcription.	MYO6 POLR2A	2.94e-05	2	189	2	16949370
Pubmed	Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum.	ALK VCL	2.94e-05	2	189	2	21076462
Pubmed	The E3 ubiquitin ligase, HECTD1, is involved in ABCA1-mediated cholesterol export from macrophages.	ABCA1 HECTD1	2.94e-05	2	189	2	29306077
Pubmed	Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1.	PABPN1 ELAVL1	2.94e-05	2	189	2	28080204
Pubmed	Spt6 levels are modulated by PAAF1 and proteasome to regulate the HIV-1 LTR.	PAAF1 SUPT6H	2.94e-05	2	189	2	22316138
Pubmed	CTCF driven TERRA transcription facilitates completion of telomere DNA replication.	DMRT2 CTCF	2.94e-05	2	189	2	29235471
Pubmed	Expression and regulation of mouse Mtsh1 during limb and branchial arch development.	TSHZ2 TSHZ1	2.94e-05	2	189	2	11668608
Pubmed	Genetic reduction of the extracellular matrix protein versican attenuates inflammatory cell infiltration and improves contractile function in dystrophic mdx diaphragm muscles.	VCAN DMD	2.94e-05	2	189	2	32632164
Pubmed	Genetic variations in genes involved in heparan sulphate biosynthesis are associated with Plasmodium falciparum parasitaemia: a familial study in Burkina Faso.	HS3ST3B1 HS3ST3A1	2.94e-05	2	189	2	22475533
Pubmed	Genetic inhibition of Anaplastic Lymphoma Kinase rescues cognitive impairments in Neurofibromatosis 1 mutant mice.	NF1 ALK	2.94e-05	2	189	2	28057529
Pubmed	Molecular dissection of the interaction of desmin with the C-terminal region of nebulin.	NEB DES	2.94e-05	2	189	2	12064939
Pubmed	Vertebrate orthologues of the Drosophila region-specific patterning gene teashirt.	TSHZ2 TSHZ1	2.94e-05	2	189	2	10704881
Pubmed	Analysis of the tissue-specific distribution of mRNAs encoding the plasma membrane calcium-pumping ATPases and characterization of an alternately spliced form of PMCA4 at the cDNA and genomic levels.	ATP2B3 ATP2B4	2.94e-05	2	189	2	1531651
Pubmed	Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development.	RXRB RXRG	2.94e-05	2	189	2	9150186
Pubmed	5-Aminolevulinate dehydratase porphyria: Update on hepatic 5-aminolevulinic acid synthase induction and long-term response to hemin.	ALAD ALAS1	2.94e-05	2	189	2	33199206
Pubmed	The glucocorticoid receptor acts locally to protect dystrophic muscle and heart during disease.	NR3C1 DMD	2.94e-05	2	189	2	38770680
Pubmed	Fetal muscle-derived cells can repair dystrophic muscles in mdx mice.	DES DMD	2.94e-05	2	189	2	17275812
Pubmed	Temporal response of desmin and dystrophin proteins to progressive resistance exercise in human skeletal muscle.	DES DMD	2.94e-05	2	189	2	16439510
Pubmed	Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice.	PANX1 DMD	2.94e-05	2	189	2	38671506
Pubmed	Nebulin binding impedes mutant desmin filament assembly.	NEB DES	2.94e-05	2	189	2	23615443
Pubmed	Three-dimensional Epigenome Statistical Model: Genome-wide Chromatin Looping Prediction.	POLR2A CTCF	2.94e-05	2	189	2	29581440
Pubmed	Variants in NEB and RIF1 genes on chr2q23 are associated with skeletal muscle index in Koreans: genome-wide association study.	NEB RIF1	2.94e-05	2	189	2	33674626
Pubmed	VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?	ALK VCL	2.94e-05	2	189	2	24698962
Pubmed	Genetic and functional analysis of SHROOM1-4 in a Chinese neural tube defect cohort.	SHROOM3 SHROOM2	2.94e-05	2	189	2	29423651
Pubmed	Enzymatic studies of the hemopoietic defect in flexed mice.	SFXN1 ALAD	2.94e-05	2	189	2	5393940
Pubmed	Post-transcriptional regulation of Pabpn1 by the RNA binding protein HuR.	PABPN1 ELAVL1	2.94e-05	2	189	2	29939290
Interaction	RNF123 interactions	DNAH3 SGSM1 PCDHGB3 NACC1 ITSN1 POLR2A SPTBN2 COPB2 PSMC1 RNF213 NR3C1 GPRIN1 DNAH14 ITPR2 SFXN1 DOCK5 DST ZNF592 VPS13A MAP3K9 PHF14 CNOT1 SNRNP200	1.91e-06	824	184	23	int:RNF123
Interaction	VCP interactions	GPHN AMPD2 KATNAL2 DDAH1 MAP7D3 ACADSB MYO6 SFTPC IFT74 VPS4B POLR2A TOM1 PSMC1 STING1 IDH2 NEB PAAF1 GTF3C5 DES RIF1 NF1 L3MBTL1 HNRNPUL2 SUPT6H FHOD1 PEX19 CSTF1 ELAVL1 ALAD FGD5 HECTD1 VCL	2.20e-06	1435	184	32	int:VCP
Interaction	NR3C1 interactions	TANC2 ZNF536 PDE6A MAP7D3 ACADSB MYO6 KDM5A NACC1 USP24 LRRC10 MUC16 NR3C1 NEB GTF3C5 RXRB SLC38A2 NBPF15 NF1 VPS13A ELAVL1 FGD5 CNOT1 ATP2B3 ZNF687 AHNAK2	2.96e-06	974	184	25	int:NR3C1
Interaction	NUP43 interactions	MAP4 KDM5A IFT74 CCDC168 ZNF318 GLOD4 SPAG5 FSIP2 BPTF RIF1 DST CTCF ZNF592 SUPT6H FAM169A CNOT1 SNRNP200 ZNF687 AHNAK2	4.78e-06	625	184	19	int:NUP43
Interaction	KCTD13 interactions	GPHN TANC2 DDAH1 ANK3 MAP4 MYO6 ITSN1 SPTBN2 TOM1 COPB2 PSMC1 ACTN3 IDH2 SHROOM2 ITPR2 ATP6V1H DST NF1 SUGP2 SNAP91 HNRNPUL2 KIAA1217 VCAN ELAVL1 DMD CNOT1 ATP2B3 SNRNP200 ATP2B4 VCL	9.63e-06	1394	184	30	int:KCTD13
Interaction	NAA40 interactions	GPHN MAP7D3 MAP4 MYO6 NACC1 POLR2A ZNF318 GLOD4 NR3C1 GPRIN1 ECH1 SPAG5 RIF1 DST SMG7 SUGP2 CTCF KIAA1217 FHOD1 FAM169A HERC4 SNRNP200 VCL AHNAK2	1.01e-05	978	184	24	int:NAA40
Interaction	NEURL4 interactions	MAP4 POLR2A PSMC1 ECH1 SPAG5 HECTD1 CCDC136 ZNF286A	1.14e-05	116	184	8	int:NEURL4
Interaction	SIRT7 interactions	MAP4 POLR2A SPTBN2 COPB2 USP24 CUL9 ZNF318 BPTF RIF1 DST NF1 SUGP2 CTCF SUPT6H ELAVL1 MTREX HECTD1 CNOT1 SNRNP200 VCL	1.62e-05	744	184	20	int:SIRT7
Interaction	PHF21A interactions	ZNF536 IFT74 VPS4B USP24 ZNF318 STING1 SPAG5 DST ZFHX4 ZNF592 ELAVL1 TAF1 ZNF687	1.70e-05	343	184	13	int:PHF21A
Interaction	YWHAH interactions	TANC2 AMPD2 SHROOM3 MAP7D3 KDM5A IFT74 HECTD4 NR3C1 ZCCHC14 SLC38A2 CCDC88C PTPDC1 DST NF1 HPCAL1 KIAA1217 VASH2 ZNF286B MAP3K9 ELAVL1 PRKD1 MTREX HECTD1 VCL AHNAK2	2.45e-05	1102	184	25	int:YWHAH
Interaction	ZDHHC14 interactions	ZDHHC14 STING1 ELAVL1	2.55e-05	7	184	3	int:ZDHHC14
Interaction	HADHB interactions	GPHN MAP4 IDH2 NR3C1 ECH1 SFXN1 DES NF1 CTCF PEX19 FGD5 MALSU1 SNRNP200 ALK VCL	3.32e-05	476	184	15	int:HADHB
Interaction	CCDC8 interactions	TDRKH MAP4 POLR2A SPTBN2 PSMC1 CUL9 ZNF318 GTF3C5 ITPR2 SFXN1 DST NF1 SUGP2 ELAVL1 FKBP8 HECTD1 CNOT1 SNRNP200	3.37e-05	656	184	18	int:CCDC8
Interaction	GATAD2A interactions	SOX5 AMPD2 NR3C1 POLR1G BPTF ZNF592 SUDS3 ELAVL1 HECTD1 ZNF687	4.18e-05	224	184	10	int:GATAD2A
Interaction	USP14 interactions	MAP4 MYO6 SPTBN2 TOM1 COPB2 PSMC1 IDH2 PAAF1 SPAG5 RIF1 ELAVL1 PHF14 CNOT1 SNRNP200 AHNAK2	4.51e-05	489	184	15	int:USP14
Interaction	C9orf78 interactions	ACADSB MAP4 MYO6 IFT74 SPTLC2 PSMC1 POLR1G GTF3C5 SFXN1 ATP6V1H POLR3B SUPT6H AP1M1 MTREX HERC4 CNOT1 SNRNP200	5.67e-05	620	184	17	int:C9orf78
Interaction	PEX14 interactions	TDRKH IFT74 ITSN1 NR3C1 ECH1 SPAG5 PEX19 PNPLA3 FKBP8 CNOT1	6.71e-05	237	184	10	int:PEX14
Interaction	YWHAG interactions	GPHN TANC2 AMPD2 SHROOM3 MAP7D3 HECTD4 USP24 STING1 ECH1 SHROOM2 SLC38A2 CCDC88C PTPDC1 DST NF1 HPCAL1 VASH2 MAP3K9 ELAVL1 AP1M1 PRKD1 MTREX HECTD1 SNRNP200 VCL AHNAK2	6.97e-05	1248	184	26	int:YWHAG
Interaction	PFN1 interactions	GPHN NACC1 IFT74 ITSN1 STING1 SPAG5 NF1 SMG7 KIAA1217 FHOD1 ELAVL1 HECTD1 CNOT1 VCL AHNAK2	7.08e-05	509	184	15	int:PFN1
Interaction	TOMM20 interactions	TDRKH STING1 ECH1 SFXN1 DST SMG7 VPS13A PEX19 ELAVL1 FKBP8	7.46e-05	240	184	10	int:TOMM20
Interaction	HDAC1 interactions	PPP4R1 ZNF536 KDM5A IFT74 VPS4B USP24 PSMC1 ZNF318 IDH2 NR3C1 POLR1G PAAF1 SPAG5 BPTF DST ZFHX4 CTCF ZNF592 SUDS3 PHF14 TAF1 HECTD1 EXOSC7 ZNF687	7.49e-05	1108	184	24	int:HDAC1
Interaction	ZNF281 interactions	TDRKH NACC1 MYNN NR3C1 POLR1G GPRIN1 RIF1 L3MBTL1 ELAVL1	8.52e-05	197	184	9	int:ZNF281
Interaction	ARF6 interactions	ANK3 MYO6 ITSN1 SPTBN2 COPB2 STING1 NR3C1 ARFIP2 TMEM222 GPRIN1 SFXN1 SLC38A2 SNAP91 FKBP8 DMD ATP2B4	9.52e-05	584	184	16	int:ARF6
Interaction	FOXJ2 interactions	ZNF536 NACC1 NR3C1 ZFHX4 ELAVL1 TSHZ1	9.82e-05	81	184	6	int:FOXJ2
Interaction	MAPK6 interactions	ANK3 MAP4 ITSN1 POLR2A PSMC1 ECH1 WDFY4 SFXN1 RIF1 METTL13 ATP6V1H DST ELAVL1 CDC6	1.21e-04	474	184	14	int:MAPK6
Interaction	MAGEA9 interactions	SH3BP1 ITPR2 POLR3B ZFHX4 SUGP2 IFFO2 ALAS1 TAF1 CNOT1	1.29e-04	208	184	9	int:MAGEA9
Interaction	BRPF3 interactions	BRPF3 NACC1 ZNF318 SUGP2 SUDS3 ELAVL1 TAF1 ZNF687	1.47e-04	166	184	8	int:BRPF3
Interaction	ZDHHC15 interactions	SHROOM3 ZNF318 TMEM222 RIF1 MCTP1 KIAA1217 DMD	1.52e-04	125	184	7	int:ZDHHC15
Interaction	C17orf78 interactions	CELSR2 ATP2B3 ATP2B4	1.55e-04	12	184	3	int:C17orf78
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	TSHZ2 ZFHX4 TSHZ1	1.32e-04	15	123	3	529
GeneFamily	AAA ATPases	KATNAL2 VPS4B PSMC1 KATNAL1	4.62e-04	53	123	4	413
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	SHROOM3 ANK3 ITSN1 RNF213 DNAH14 KIAA1217 VPS13A PAM NRG3	5.62e-06	176	189	9	M39223
Coexpression	GABRIELY_MIR21_TARGETS	DDAH1 SFXN1 PTPDC1 POLR3B VASH2 VPS13A TAF1 DMD HECTD1 ATP2B4 ZNF286A	8.75e-06	289	189	11	M2196
Coexpression	GSE3982_DC_VS_TH2_DN	MAP7D3 SPTBN2 ZDHHC14 GLOD4 IL18R1 STC1 SFXN1 TXNDC15 CTCF	1.51e-05	199	189	9	M5486
Coexpression	GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS	MAP7D3 TSHZ2 STEAP4 STC1 MCTP1 SNAP91 VCAN PITX1 PAM EGFLAM FGD5 DMD MX2 ZNF687	1.95e-05	505	189	14	M39167
Coexpression	AIZARANI_LIVER_C30_HEPATOCYTES_4	ABCA1 SGSM1 PDE6A TSHZ2 ITSN1 STEAP4 IDH2 ITPR2 DST SUGP2 AP1M1 PNPLA3 ALAS1	2.32e-05	446	189	13	M39129
Coexpression	LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2	GPHN SHROOM3 TSHZ2 ZDHHC14 DST NRG3	3.78e-05	86	189	6	M39248
Coexpression	MARTINEZ_TP53_TARGETS_DN	SOX5 ANK3 MAP4 POLR2A SPTBN2 ZDHHC14 BBIP1 ACTN3 SEPHS2 CELSR2 PABPN1 SUPT6H IFFO2 DMD MTREX	4.31e-05	615	189	15	M8673
Coexpression	YAGI_AML_WITH_INV_16_TRANSLOCATION	DNAH3 COPB2 ZNF318 NR3C1 ECH1 ZCCHC14 CLIP3 NF1 VPS13A TAF1 DMD ST18	4.73e-05	411	189	12	M1047
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	KDM5A ITSN1 USP24 NR3C1 BPTF RIF1 ATP6V1H DST CTCF HPCAL1 VPS13A FAM169A PHF14 DMD MTREX HERC4 ATP2B4 VCL	5.14e-05	856	189	18	M4500
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	TANC2 SOX5 PPP4R1 SHROOM3 MAP7D3 ACADSB MUC16 RNF213 ECH1 ITPR2 SLC38A2 DST ZFHX4 HPCAL1 TSHZ1 PRKD1 HS3ST3A1 USP27X HERC4 CNOT1 ATP2B3	6.40e-06	791	186	21	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#1_top-relative-expression-ranked_1000	ACTN3 SYT7 DOCK5 PTPDC1 CLIP3 ZFHX4 TSHZ1 PRKD1 USP27X ZNF286A	8.93e-06	195	186	10	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	GPHN TDRKH KATNAL2 ZNF536 HECTD4 NEB SPAG5 PTPDC1 CLIP3 RIF1 DST CELSR2 VPS13A FAM169A PAM PHF14 DMD CLSPN	1.89e-05	654	186	18	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	SOX5 KATNAL2 ZNF536 BRPF3 SHROOM3 SGSM1 DDAH1 IFT74 SPTBN2 ACTN3 SHROOM2 IL18R1 SPAG5 STC1 CCDC88C BPTF CLIP3 L3MBTL1 CELSR2 SNAP91 CTCF VPS13A FAM169A PHF14 DMD NRG3 CLSPN ANKFN1	2.42e-05	1370	186	28	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200	TSHZ2 MUC16 STC1 KIAA1217 VCAN EGFLAM HS3ST3A1 ATP2B4	4.71e-05	147	186	8	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	MAP7D3 TSHZ2 MUC16 RNF213 STING1 STC1 ITPR2 CLIP3 ZFHX4 KIAA1217 VCAN VASH2 PAM TSHZ1 ALAD PRKD1 HS3ST3A1 ATP2B3 ATP2B4	7.74e-05	797	186	19	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#3	KATNAL2 ZNF536 CCDC88C CLIP3 DST CELSR2 PAM	8.22e-05	118	186	7	Facebase_RNAseq_e8.5_Floor Plate_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	KATNAL2 KDM5A POLR2A USP24 BPTF PTPDC1 CLIP3 RIF1 SUPT6H FAM169A TAF1 DMD MTREX CLSPN USP27X HECTD1	1.40e-04	629	186	16	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000	SOX5 USE1 BBIP1 RNF213 ZNF318 ITPR2 RIF1 ATP6V1H PRKD1	1.40e-04	219	186	9	gudmap_developingGonad_e16.5_ovary_1000_k5
CoexpressionAtlas	kidney_P1_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500	TDRKH SHROOM3 DOCK5 DST	1.49e-04	31	186	4	gudmap_kidney_P1_CapMes_Crym_k3_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	TDRKH KATNAL2 ZNF536 MAP7D3 IFT74 POLR1G SPAG5 CCDC88C CLIP3 RIF1 SMG7 CELSR2 HNRNPUL2 VPS13A FAM169A PHF14 DMD CDC6 CLSPN HECTD1 ST18	1.63e-04	989	186	21	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#5	MAP7D3 POLR1G CCDC88C CELSR2 FAM169A	1.95e-04	61	186	5	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX5 ZNF536 ANK3 TSHZ2 ZFHX4 DMD NRG3 HS3ST3A1 AHNAK2	1.02e-07	185	189	9	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	SOX5 PPP4R1 SHROOM3 ANK3 MYO6 SFTPC STEAP4 DNAH14 DOCK5	1.17e-07	188	189	9	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SOX5 ANK3 MYO6 SFTPC STEAP4 DNAH14 HPCAL1 KIAA1217 PRKD1	1.40e-07	192	189	9	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GPHN TANC2 SOX5 SHROOM3 ANK3 MYO6 SFTPC STEAP4 PRKD1	1.47e-07	193	189	9	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GPHN TANC2 SOX5 SHROOM3 ANK3 MYO6 SFTPC STEAP4 PRKD1	1.47e-07	193	189	9	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ANK3 TSHZ2 USP24 AKNA RNF213 SUGP2 VPS13A FAM169A ALK	1.47e-07	193	189	9	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GPHN SOX5 SHROOM3 ANK3 MYO6 SFTPC STEAP4 DNAH14 PAM	1.53e-07	194	189	9	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 MYO6 SYT7 RIF1 DST VPS13A TSHZ1 ST18 SEZ6L	1.60e-07	195	189	9	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 MYO6 SYT7 RIF1 DST VPS13A TSHZ1 ST18 SEZ6L	1.60e-07	195	189	9	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SOX5 ANK3 TSHZ2 ITSN1 C19orf81 ZFHX4 TSHZ1 DMD HS3ST3A1	1.90e-07	199	189	9	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate\|2m / Sample Type, Dataset, Time_group, and Cell type.	SOX5 ANK3 DST NF1 HPCAL1 VCAN PHF14 HECTD1 ST18	1.99e-07	200	189	9	2a635694844ddabcd98462c5636a6f41a3f08a46
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SOX5 ANK3 TSHZ2 ITSN1 DES TSHZ1 DMD HS3ST3A1 VCL	1.99e-07	200	189	9	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ANK3 MYO6 TSHZ2 MUC16 DST KIAA1217 PITX1 HECTD1 AHNAK2	1.99e-07	200	189	9	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZNF536 ANK3 RXRG DOCK5 KIRREL3 DST KIAA1217 ALK	6.26e-07	168	189	8	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	GPHN TANC2 SOX5 SHROOM3 ANK3 SFTPC STEAP4 PRKD1	1.05e-06	180	189	8	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 MYO6 SPTBN2 ITPR2 DST DMRT2 FAM169A ALPK3	1.46e-06	188	189	8	e751cff2ac8fbc1487766c1871fcc5d1005286b0
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 SHROOM3 ANK3 MYO6 SPTBN2 CCDC88C DMRT2 EXOSC7	1.52e-06	189	189	8	532aaf02b364c5c4f58a2021c7c21d86df3875c9
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	SOX5 SHROOM3 DDAH1 ANK3 MYO6 DNAH14 CELSR2 KIAA1217	1.64e-06	191	189	8	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature-Adult_Glia\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 ANK3 RXRG DOCK5 KIRREL3 DST ZFHX4 ALK	1.85e-06	194	189	8	d429bb5e422a07bd92f0dc48cd51528e8b7d9a72
ToppCell	3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 ANK3 RXRG DOCK5 KIRREL3 DST ZFHX4 ALK	1.85e-06	194	189	8	408dfc7060095972a54ae37ae8105521df6fbbee
ToppCell	3'-Pediatric_IBD-SmallIntestine-Neuronal\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 ANK3 RXRG DOCK5 KIRREL3 DST ZFHX4 ALK	1.85e-06	194	189	8	bffdf6db0bf3fb338e7bb0789ae7dcde1fce0094
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DIPK1C STING1 IL18R1 C19orf81 DOCK5 SLC38A2 DST SNAP91	1.92e-06	195	189	8	d70b49f6b9c6c4422adb2936c837a1af7569fb0a
ToppCell	Control-Multiplet-Multiplet\|Control / Disease state, Lineage and Cell class	SOX5 SHROOM3 ANK3 SFTPC STEAP4 KIAA1217 PRKD1 ATP2B4	1.92e-06	195	189	8	06ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCell	Control-Multiplet\|Control / Disease state, Lineage and Cell class	SOX5 SHROOM3 ANK3 SFTPC STEAP4 KIAA1217 PRKD1 ATP2B4	1.92e-06	195	189	8	618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	GPHN TANC2 SOX5 SHROOM3 ANK3 PRKD1 DMD HERC4	1.99e-06	196	189	8	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	GPHN TANC2 SOX5 SHROOM3 ANK3 NF1 PRKD1 DMD	2.15e-06	198	189	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ANK3 USP24 AKNA RNF213 BPTF SUGP2 VPS13A SNRNP200	2.23e-06	199	189	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP7D3 ANK3 ITSN1 DES TSHZ1 DMD HS3ST3A1 VCL	2.32e-06	200	189	8	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	TSHZ2 ITSN1 DES DST TSHZ1 DMD HS3ST3A1 VCL	2.32e-06	200	189	8	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 SHROOM3 SPTBN2 SHROOM2 CCDC88C DMRT2 EXOSC7	5.16e-06	158	189	7	debebc8534a80e5500051f6fd352dc201585968d
ToppCell	LV-16._Neuronal\|World / Chamber and Cluster_Paper	ZNF536 ANK3 RXRG DOCK5 KIRREL3 KIAA1217 ALK	6.86e-06	165	189	7	6ed52cb756d21addf46c7f6c457458b01339fe04
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	ABCA1 SHROOM3 ANK3 MYO6 DST HPCAL1 NRG3	8.33e-06	170	189	7	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	COVID-19-Heart-Neuronal\|Heart / Disease (COVID-19 only), tissue and cell type	ZNF536 ANK3 RXRG DOCK5 KIRREL3 KIAA1217 ALK	9.34e-06	173	189	7	6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7
ToppCell	PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TDRKH NACC1 SH3BP1 WDFY4 MAP3K9 CDC6 CLSPN	9.70e-06	174	189	7	09b091e24317c3f7bac043f04762a533e30793de
ToppCell	B_cells-pDCs\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	ATP13A2 IL18R1 KIRREL3 DST MCTP1 VASH2 HS3ST3B1	1.04e-05	176	189	7	ce757de9e09a225f3f96433f103f43619b0e0dda
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ2 CLIP3 KIAA1217 EGFLAM HS3ST3B1 HS3ST3A1 CCDC136	1.04e-05	176	189	7	a4d269075aa0efc46fa251b379f334e50c69391d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ2 CLIP3 KIAA1217 EGFLAM HS3ST3B1 HS3ST3A1 CCDC136	1.04e-05	176	189	7	cc6f65a7d2c622841c9d1ab3755586039d4ccc4d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ2 CLIP3 KIAA1217 EGFLAM HS3ST3B1 HS3ST3A1 CCDC136	1.04e-05	176	189	7	e9152defb4fd41267fb33c42c01fd0c683280783
ToppCell	wk_15-18-Epithelial-PNS-Schwann_precursor\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	SOX5 ZNF536 NF1 CELSR2 EGFLAM CLSPN ALK	1.08e-05	177	189	7	5357359e6c2161a37f39a6b3b78449f5cbc327d1
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NR3C1 ATP13A2 WDFY4 KIRREL3 SNAP91 VASH2 HS3ST3B1	1.08e-05	177	189	7	8887ff6341eb070bdaa890cc2cd7745f0cf1b0af
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NR3C1 ATP13A2 WDFY4 KIRREL3 SNAP91 VASH2 HS3ST3B1	1.08e-05	177	189	7	507f06d31ab773099c9431b6f433899dc97b5566
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TANC2 ANK3 TSHZ2 MUC16 KIAA1217 IFFO2 PNPLA3	1.17e-05	179	189	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	ZNF536 TSHZ2 KIRREL3 DST VCAN NRG3 SERPINA7	1.17e-05	179	189	7	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX5 ZNF536 TSHZ2 CLIP3 ZFHX4 DMD HS3ST3A1	1.17e-05	179	189	7	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ZNF536 ANK3 RXRG C19orf81 DOCK5 ZFHX4 VCAN	1.21e-05	180	189	7	1e819c5c87704ec6535dfeaae56561895e239d07
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 MYO6 ZDHHC14 SYT7 DST PRKD1 HECTD1	1.30e-05	182	189	7	a8cc56f32efe180e8fb5d69dbe606a794b3db700
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	SOX5 SHROOM3 ANK3 MYO6 SFTPC STEAP4 PRKD1	1.35e-05	183	189	7	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF536 TSHZ2 ZFHX4 TSHZ1 DMD NRG3 HS3ST3A1	1.35e-05	183	189	7	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SOX5 TSHZ2 STC1 CLIP3 VCAN VASH2 HS3ST3A1	1.35e-05	183	189	7	f4ea7113ce9099222743d9ff02388d3d8a9e987b
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast\|E18.5-samps / Age Group, Lineage, Cell class and subclass	ZNF536 TSHZ2 ITSN1 DES SUGP2 VCAN TSHZ1	1.35e-05	183	189	7	de08f9ea02b7244d5a8788064631d10f06565337
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3\|lymph-node_spleen / Manually curated celltypes from each tissue	DIPK1C ABCA1 IL18R1 C19orf81 DST SNAP91 KIAA1217	1.39e-05	184	189	7	479e60f76c191253e23699c9dd7ef7efc08c59ad
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	ANK3 MAP4 DES DST PAM DMD VCL	1.39e-05	184	189	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	5'-Adult-LargeIntestine-Neuronal-Glial_mature\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 ANK3 RXRG KIRREL3 DST DMD ALK	1.44e-05	185	189	7	f607b6ee579562e2f92103fa5c7053df0170a229
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ABCA1 TSHZ2 HECTD4 ZDHHC14 ITPR2 DMD ST18	1.44e-05	185	189	7	1d874608aa2062024323512f68889219471b2f00
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX5 ZNF536 ANK3 TSHZ2 ZFHX4 DMD HS3ST3A1	1.44e-05	185	189	7	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	5'-Adult-LargeIntestine-Neuronal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 ANK3 RXRG KIRREL3 DST DMD ALK	1.44e-05	185	189	7	317f2c854f00aa5957319b818c85eeed7d72ec7f
ToppCell	5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 ANK3 RXRG KIRREL3 DST DMD ALK	1.44e-05	185	189	7	7bb8fdfe04f85d25056380ec58222366de323a21
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX5 ZNF536 ANK3 DES CLIP3 DMD HS3ST3A1	1.49e-05	186	189	7	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 MYO6 SPTBN2 ITPR2 DST DMRT2 ALPK3	1.49e-05	186	189	7	a6ef5d5944af5689b5f27bef89cd05645eedbe50
ToppCell	Influenza-Influenza_Severe-Myeloid-Neutrophil\|Influenza_Severe / Disease, condition lineage and cell class	SOX5 ABCA1 STEAP4 IL18R1 CFAP92 VASH2 MX2	1.49e-05	186	189	7	1dfcec9196d4db76fba3abc74e85885b1fb98b87
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ITSN1 AKNA ITPR2 DOCK5 DST SUGP2 HECTD1	1.55e-05	187	189	7	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EARS2 NACC1 ZDHHC14 ATP13A2 WDFY4 C19orf81 VASH2	1.55e-05	187	189	7	d3563bb087e476baea5b59389e4d34d0ff98cac5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 SOX5 ANK3 SPTBN2 STC1 MCTP1 ALAS1	1.60e-05	188	189	7	e30a4ddac0da8cdcf621d98e28e3895cd9307e7a
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX5 ZNF536 ANK3 DES CLIP3 DMD HS3ST3A1	1.60e-05	188	189	7	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX5 ZNF536 ANK3 DES CLIP3 DMD HS3ST3A1	1.60e-05	188	189	7	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO6 ZDHHC14 SHROOM2 KIAA1217 FGD5 NRG3 ATP2B4	1.66e-05	189	189	7	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	ANK3 ZDHHC14 ALPK3 PAM DMD HS3ST3A1 ATP2B4	1.71e-05	190	189	7	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 SOX5 ANK3 SPTBN2 STC1 MCTP1 ALAS1	1.71e-05	190	189	7	11d3c31167ea71809b4cc3757a0c6ea54a448602
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 SOX5 ANK3 SPTBN2 STC1 MCTP1 ALAS1	1.71e-05	190	189	7	b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	SOX5 SHROOM3 DDAH1 ANK3 MYO6 DNAH14 KIAA1217	1.83e-05	192	189	7	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	KDM5A ITPR2 BPTF VCAN FAM169A PRKD1 MTREX	1.83e-05	192	189	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	KDM5A POLR1G BPTF NBPF15 SUGP2 VPS13A AHNAK2	1.83e-05	192	189	7	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	SOX5 SHROOM3 DDAH1 ANK3 MYO6 DNAH14 KIAA1217	1.83e-05	192	189	7	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ2 ITSN1 STEAP4 SLC38A2 ZFHX4 DMD VCL	1.90e-05	193	189	7	c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	SOX5 ZNF536 TSHZ2 DST PRKD1 DMD HS3ST3A1	1.90e-05	193	189	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO6 ZDHHC14 MCTP1 KIAA1217 EGFLAM FGD5 ATP2B4	1.90e-05	193	189	7	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ2 ITSN1 STEAP4 SLC38A2 ZFHX4 DMD VCL	1.90e-05	193	189	7	5b602b1702283184bd3943c2a6f2290b7c37e407
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SOX5 SHROOM3 DDAH1 ANK3 MYO6 DNAH14 KIAA1217	1.90e-05	193	189	7	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	IPF-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	MYO6 ZDHHC14 GVINP1 KIAA1217 NRG3 ATP2B4 VCL	1.96e-05	194	189	7	777ce41c3f22c591e2d81120f189b834e53ffb4b
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SOX5 TSHZ2 ZDHHC14 DOCK5 DST ZFHX4 VCAN	1.96e-05	194	189	7	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	SOX5 DNAH3 SHROOM3 ANK3 NEK5 KIAA1217 ANKFN1	2.03e-05	195	189	7	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	KDM5A AKNA RNF213 CCDC88C NEK5 VPS13A EXOSC7	2.03e-05	195	189	7	83c125223e7ca0f08a31414b3a16347912564765
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	SOX5 DNAH3 SHROOM3 ANK3 NEK5 KIAA1217 ANKFN1	2.03e-05	195	189	7	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOX5 ZNF536 NR3C1 STC1 DES TSHZ1 EGFLAM	2.03e-05	195	189	7	2414b158dc7bdec43a9671544bfb7ffc5f5168fd
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOX5 ZNF536 TSHZ2 NR3C1 STC1 TSHZ1 EGFLAM	2.03e-05	195	189	7	b0d408f8bc1701a87596ed55efcd90749fee33e6
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF536 TSHZ2 STC1 DES CLIP3 TSHZ1 EGFLAM	2.03e-05	195	189	7	2514c1f23424b5fc664d326d31ffd22bafe74ef8
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SOX5 TSHZ2 ZDHHC14 DOCK5 DST ZFHX4 VCAN	2.03e-05	195	189	7	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 DES PITX1 DMD VCL SEZ6L AHNAK2	2.03e-05	195	189	7	eb2003d4f15cad213d17eda8ab7479f5a0c62164
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 DES PITX1 DMD VCL SEZ6L AHNAK2	2.03e-05	195	189	7	44f67437ea65d530133a0240b17f9860d9cc0e99
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GPHN SOX5 SHROOM3 ANK3 MYO6 SFTPC DNAH14	2.03e-05	195	189	7	9406866f99555198a9be311fbd65751b70f35446
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOX5 ZNF536 TSHZ2 NR3C1 STC1 TSHZ1 EGFLAM	2.03e-05	195	189	7	a486a7acea0e91048cc48afa0dbd3926d30bc217
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ2 ITSN1 SLC38A2 ZFHX4 VCAN DMD VCL	2.09e-05	196	189	7	3a6c942e2907aa07b5e12dbf9019d18f7bfca507
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ2 ITSN1 SLC38A2 ZFHX4 VCAN DMD VCL	2.09e-05	196	189	7	bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ANK3 TSHZ2 USP24 RNF213 VPS13A FAM169A SNRNP200	2.16e-05	197	189	7	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TANC2 ANK3 TSHZ2 RNF213 SFXN1 SUGP2 VPS13A	2.16e-05	197	189	7	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	mLN-B_cell-B_cell_cycling\|B_cell / Region, Cell class and subclass	NEB SPAG5 POLR3B KIAA1217 DMD CDC6 CLSPN	2.16e-05	197	189	7	2071526fe46de8359ea118ff78581eb4454aa55a
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	KATNAL2 AKNA RNF213 SUPT6H TSHZ1 ATP2B4 MX2	2.24e-05	198	189	7	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TSHZ2 DES DST ZFHX4 TSHZ1 DMD HS3ST3A1	2.31e-05	199	189	7	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	GPHN SOX5 ANK3 ITPR2 NF1 DMD HERC4	2.31e-05	199	189	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 SHROOM3 ANK3 MYO6 DNAH14 DOCK5 HPCAL1	2.31e-05	199	189	7	8587bd98de7767a575088afbea07a1feb4516b9b
Drug	Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	SLC9A8 SFTPC ITSN1 NR3C1 NEB STC1 ITPR2 NF1 VASH2 FKBP8 HS3ST3A1	6.38e-07	194	187	11	4424_DN
Drug	N-Acetyl-L-leucine [1188-21-2]; Down 200; 23uM; MCF7; HT_HG-U133A	TDRKH DNAH3 TOM1 GTF3C5 DOCK5 NF1 MCTP1 SMG7 ZNF592 MAP3K9 FKBP8	7.07e-07	196	187	11	6462_DN
Drug	Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; PC3; HT_HG-U133A	TDRKH MAP4 SPTLC2 CUL9 ZNF318 TMEM222 STC1 PITX1 VPS13A FKBP8	4.68e-06	193	187	10	7147_UP
Drug	felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA	DNAH3 ACADSB MAP4 IFT74 SPTLC2 ITSN1 ZNF318 STC1 SUGP2 HNRNPUL2	5.36e-06	196	187	10	848_DN
Drug	Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A	DNAH3 ABCA1 STEAP4 CUL9 SHROOM2 CCDC88C ZFHX4 SUPT6H VCAN VASH2	5.36e-06	196	187	10	5827_DN
Drug	Harmine hydrochloride [343-27-1]; Up 200; 16uM; HL60; HG-U133A	ABCA1 MAP4 KDM5A SFTPC MYNN PAAF1 L3MBTL1 SUGP2 HNRNPUL2 CDC6	5.61e-06	197	187	10	1758_UP
Drug	Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	TDRKH MAP4 SPTLC2 NEB STC1 NF1 ZFHX4 VASH2 PEX19 FAM169A	5.86e-06	198	187	10	6043_DN
Drug	Amrinone [60719-84-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A	TDRKH MAP4 SFTPC POLR2A DOCK5 ZCCHC14 ZNF592 SUPT6H FAM169A MAP3K9	6.13e-06	199	187	10	6826_DN
Drug	Helveticoside [630-64-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	MAP7D3 KDM5A ITSN1 ZNF318 PAAF1 ITPR2 METTL13 POLR3B AHNAK2	2.43e-05	186	187	9	3851_DN
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	TDRKH SCN11A MAP4 KDM5A SFTPC NEB STC1 SMG7 HNRNPUL2	3.38e-05	194	187	9	4320_DN
Drug	Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A	DNAH3 ABCA1 SFTPC NEB ITPR2 DOCK5 NF1 SMG7 VASH2	3.52e-05	195	187	9	5388_DN
Drug	Berberine chloride [633-65-8]; Up 200; 10.8uM; MCF7; HT_HG-U133A	SLC9A8 MAP4 KDM5A ITPR2 ZCCHC14 PHF14 FKBP8 SNRNP200 SEZ6L	3.52e-05	195	187	9	2770_UP
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; MCF7; HT_HG-U133A	MAP4 CUL9 ZNF318 NR3C1 STC1 NF1 TAF1 HS3ST3A1 ATP2B4	3.52e-05	195	187	9	5283_UP
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	MAP4 ITSN1 POLR2A ZNF318 IDH2 ITPR2 SUGP2 PABPN1 SUPT6H	3.52e-05	195	187	9	1649_DN
Drug	Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A	DNAH3 KDM5A IFT74 NEB STC1 DOCK5 NF1 SMG7 HNRNPUL2	3.67e-05	196	187	9	5425_DN
Drug	Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A	TDRKH DNAH3 ABCA1 SCRN3 DOCK5 RIF1 NF1 SMG7 TAF1	3.67e-05	196	187	9	3534_DN
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A	TDRKH MAP4 SFTPC STEAP4 IDH2 POLR1G NF1 SMG7 FKBP8	3.67e-05	196	187	9	4697_DN
Drug	Pinacidil [85371-64-8]; Down 200; 16.4uM; HL60; HT_HG-U133A	MAP4 KDM5A ZDHHC14 IDH2 CELSR2 SUPT6H FHOD1 VCAN TAF1	3.67e-05	196	187	9	2406_DN
Drug	Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A	TANC2 MAP4 NR3C1 GTF3C5 ITPR2 SMG7 HNRNPUL2 PITX1 HERC4	3.82e-05	197	187	9	2848_DN
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MAP4 KDM5A SPTLC2 NR3C1 ATP13A2 DOCK5 SMG7 SUGP2 VASH2	3.82e-05	197	187	9	2307_DN
Drug	Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A	MAP4 MYO6 KDM5A SPTLC2 TMEM222 HNRNPUL2 VASH2 FKBP8 HERC4	3.82e-05	197	187	9	3442_UP
Drug	Cinoxacin [28657-80-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A	ZDHHC14 NR3C1 NEB ZCCHC14 NF1 VPS13A TAF1 ATP2B4 AHNAK2	3.82e-05	197	187	9	3463_UP
Drug	Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A	ITSN1 USP24 STEAP4 ZNF318 DOCK5 ZCCHC14 CCDC88C FKBP8 HERC4	3.82e-05	197	187	9	5302_UP
Drug	Carcinine [56897-53-1]; Down 200; 22uM; MCF7; HT_HG-U133A	GPHN GLOD4 TMEM222 METTL13 HNRNPUL2 PEX19 ELAVL1 FKBP8 HERC4	3.97e-05	198	187	9	4809_DN
Drug	Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; HL60; HT_HG-U133A	DDAH1 MAP7D3 MAP4 KDM5A CUL9 ZNF318 NF1 SMG7 VCAN	3.97e-05	198	187	9	2349_UP
Drug	0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A	SLC9A8 ITSN1 ZDHHC14 NEB NF1 SMG7 PITX1 PHF14 TAF1	3.97e-05	198	187	9	6426_DN
Drug	Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A	MAP4 SPTLC2 USP24 CCDC88C NF1 SUGP2 SUPT6H PITX1 FKBP8	3.97e-05	198	187	9	3482_UP
Drug	Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A	SPTLC2 SPTBN2 ZNF318 SMG7 SUGP2 SUPT6H PITX1 VASH2 HERC4	3.97e-05	198	187	9	3326_DN
Drug	Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; PC3; HT_HG-U133A	TDRKH ACADSB STC1 DES NF1 L3MBTL1 SMG7 PITX1 VCL	3.97e-05	198	187	9	4482_DN
Drug	Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	TDRKH MAP4 KDM5A IFT74 SPTLC2 CCDC88C NF1 PITX1 ATP2B4	3.97e-05	198	187	9	6001_DN
Drug	Dimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; MCF7; HT_HG-U133A	SCN11A ABCA1 ZNF318 ITPR2 DES HNRNPUL2 PITX1 TAF1 AHNAK2	3.97e-05	198	187	9	6520_UP
Drug	Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A	TDRKH KDM5A ZDHHC14 STC1 ZCCHC14 NF1 MAP3K9 PHF14 MX2	3.97e-05	198	187	9	2755_UP
Drug	Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; MCF7; HT_HG-U133A	TANC2 SLC9A8 MAP4 ITSN1 DOCK5 NF1 VASH2 FKBP8 AHNAK2	4.29e-05	200	187	9	1524_UP
Drug	diazepinylbenzoic acid	ABCA1 RXRB RXRG	6.27e-05	10	187	3	ctd:C438269
Drug	2,2',3,3',4,4',6,6'-octabromodiphenyl ether	ALAD ALAS1	6.71e-05	2	187	2	ctd:C511855
Drug	UVI 3003	ABCA1 RXRB RXRG	8.57e-05	11	187	3	ctd:C525131
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	MAP4 ITSN1 NEB STC1 ITPR2 VPS13A FAM169A HERC4	1.25e-04	180	187	8	2859_DN
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	AMPD2 MAP7D3 POLR1G STC1 NF1 SMG7 CELSR2 FHOD1	1.35e-04	182	187	8	1043_DN
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	TANC2 MAP4 MYO6 KDM5A DOCK5 HNRNPUL2 VASH2 HERC4	1.75e-04	189	187	8	4304_DN
Drug	Sulfonamides	NR3C1 RXRB RXRG	1.86e-04	14	187	3	ctd:D013449
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	MAP4 SPTLC2 NF1 L3MBTL1 SMG7 VCAN FAM169A PRKD1	1.88e-04	191	187	8	6644_DN
Drug	Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; PC3; HT_HG-U133A	TDRKH SPTLC2 ZDHHC14 NEB STC1 NF1 SMG7 CELSR2	1.95e-04	192	187	8	7364_UP
Drug	Bexarotene	RXRB RXRG	2.00e-04	3	187	2	DB00307
Drug	2-hydroxyphytanic acid	RXRB RXRG	2.00e-04	3	187	2	ctd:C002585
Drug	AC1O5SBP	RXRB RXRG	2.00e-04	3	187	2	CID006439746
Drug	D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A	DNAH3 MAP4 KDM5A SPTLC2 ZNF318 IDH2 HNRNPUL2 HERC4	2.02e-04	193	187	8	3562_DN
Drug	Clotrimazole [23593-75-1]; Down 200; 11.6uM; PC3; HT_HG-U133A	AMPD2 ABCA1 STEAP4 IDH2 FHOD1 ALAD TAF1 FKBP8	2.02e-04	193	187	8	5726_DN
Drug	Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A	MAP4 ZDHHC14 NR3C1 STC1 ITPR2 SFXN1 ZCCHC14 CCDC88C	2.02e-04	193	187	8	2748_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A	TANC2 MAP4 NEB ATP13A2 STC1 SMG7 HNRNPUL2 VPS13A	2.02e-04	193	187	8	3412_DN
Drug	Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	MAP4 SPTLC2 USP24 ZNF318 NR3C1 SUPT6H FHOD1 ELAVL1	2.09e-04	194	187	8	7406_DN
Drug	Pyrilamine maleate [59-33-6]; Down 200; 10uM; MCF7; HT_HG-U133A	KDM5A SPTLC2 TOM1 ZNF318 NR3C1 ZCCHC14 NF1 TAF1	2.09e-04	194	187	8	3184_DN
Drug	17-AAG; Down 200; 1uM; HL60; HT_HG-U133A	DNAH3 MAP7D3 MAP4 POLR1G CCDC88C SMG7 HNRNPUL2 FHOD1	2.09e-04	194	187	8	1147_DN
Drug	Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	SPTLC2 SHROOM2 BPTF SMG7 HNRNPUL2 VPS13A ALAD TAF1	2.09e-04	194	187	8	4662_DN
Drug	Tiabendazole [148-79-8]; Down 200; 19.8uM; MCF7; HT_HG-U133A	ABCA1 ACADSB SFTPC ZDHHC14 NR3C1 VASH2 FKBP8 MX2	2.17e-04	195	187	8	4402_DN
Drug	Calycanthine [595-05-1]; Down 200; 11.6uM; PC3; HT_HG-U133A	SCN11A TOM1 STEAP4 ITPR2 CCDC88C VCAN MAP3K9 FKBP8	2.17e-04	195	187	8	5744_DN
Drug	thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	SCRN3 ZDHHC14 POLR1G ITPR2 ZCCHC14 NF1 PITX1 HS3ST3A1	2.17e-04	195	187	8	5590_DN
Drug	Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A	ANK3 MAP4 STEAP4 CUL9 ZCCHC14 NF1 VASH2 FKBP8	2.17e-04	195	187	8	4686_DN
Drug	Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; HL60; HT_HG-U133A	SCRN3 MAP4 GTF3C5 ITPR2 DOCK5 SMG7 HNRNPUL2 TAF1	2.17e-04	195	187	8	2708_DN
Drug	Arcaine sulfate [14923-17-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A	SLC9A8 MAP4 SPTLC2 SMG7 ZFHX4 PHF14 HERC4 ATP2B4	2.24e-04	196	187	8	4974_UP
Drug	estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A	TDRKH KDM5A NEB DES VASH2 MAP3K9 HS3ST3A1 AHNAK2	2.24e-04	196	187	8	5568_DN
Drug	Colistin sulfate [1264-72-8]; Down 200; 3uM; MCF7; HT_HG-U133A	MAP4 ZDHHC14 NEB ATP13A2 STC1 ITPR2 VASH2 HERC4	2.24e-04	196	187	8	2851_DN
Drug	Allantoin [97-59-6]; Down 200; 25.2uM; MCF7; HT_HG-U133A	ACADSB MAP4 CUL9 PABPN1 SUPT6H FHOD1 PITX1 FKBP8	2.24e-04	196	187	8	1678_DN
Drug	Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	MAP4 KDM5A SPTLC2 NR3C1 STC1 ZCCHC14 DES SEZ6L	2.24e-04	196	187	8	3314_UP
Drug	chlorpromazine hydrochloride; Down 200; 10uM; MCF7; HG-U133A	MYO6 SFTPC SPTLC2 HNRNPUL2 SUPT6H VPS13A CSTF1 PAM	2.24e-04	196	187	8	419_DN
Drug	Levonordefrin [829-74-3]; Up 200; 21.8uM; MCF7; HT_HG-U133A	TDRKH ITSN1 CUL9 NEB STC1 L3MBTL1 ZFHX4 MAP3K9	2.24e-04	196	187	8	7208_UP
Drug	Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; PC3; HT_HG-U133A	TANC2 MAP7D3 NEB RIF1 NF1 L3MBTL1 ALPK3 ALK	2.24e-04	196	187	8	3726_DN
Drug	Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	MAP7D3 KDM5A IFT74 CUL9 ATP13A2 ZCCHC14 PITX1 TAF1	2.24e-04	196	187	8	5438_DN
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; HL60; HT_HG-U133A	MAP4 KDM5A IFT74 NF1 L3MBTL1 SMG7 HNRNPUL2 ALAD	2.24e-04	196	187	8	6141_DN
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A	TDRKH SPTLC2 NEB GTF3C5 SMG7 CELSR2 MAP3K9 FKBP8	2.24e-04	196	187	8	1666_UP
Drug	Apramycin [37321-09-8]; Down 200; 7.4uM; HL60; HT_HG-U133A	SLC9A8 MAP4 KDM5A IFT74 USP24 SMG7 SUGP2 PEX19	2.24e-04	196	187	8	2914_DN
Drug	Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	SFTPC POLR2A BBIP1 CUL9 NF1 ZFHX4 SUPT6H FKBP8	2.24e-04	196	187	8	3256_UP
Drug	Betazole hydrochloride; Down 200; 27uM; PC3; HT_HG-U133A	AMPD2 SCRN3 ITPR2 MCTP1 CELSR2 VCAN PITX1 VPS13A	2.24e-04	196	187	8	6344_DN
Drug	Gly-His-Lys acetate salt; Up 200; 1uM; PC3; HT_HG-U133A	GPHN MAP4 SPTLC2 ZNF318 ATP13A2 SMG7 HPCAL1 HERC4	2.24e-04	196	187	8	6570_UP
Drug	Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	SCRN3 MAP4 SFTPC ITSN1 DOCK5 NF1 CELSR2 SUPT6H	2.24e-04	196	187	8	5341_UP
Drug	PNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A	GPHN MAP4 SPTLC2 SMG7 MAP3K9 PHF14 FKBP8 HERC4	2.24e-04	196	187	8	6568_UP
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A	SPTLC2 STEAP4 NEB STC1 DOCK5 NF1 SMG7 PITX1	2.32e-04	197	187	8	5436_DN
Drug	Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	MAP4 SPTLC2 TOM1 ZDHHC14 ITPR2 DES MAP3K9 MX2	2.32e-04	197	187	8	3934_DN
Drug	rofecoxib; Down 200; 10uM; HL60; HG-U133A	DNAH3 ANK3 MAP4 ITSN1 SH3BP1 ZNF318 ITPR2 FKBP8	2.32e-04	197	187	8	371_DN
Drug	Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A	MAP4 ZDHHC14 NR3C1 ZCCHC14 CCDC88C NF1 MAP3K9 FKBP8	2.32e-04	197	187	8	3447_UP
Drug	Meglumine [6284-40-8]; Up 200; 20.4uM; MCF7; HT_HG-U133A	SLC9A8 CUL9 IDH2 NF1 SUGP2 SUPT6H TAF1 FKBP8	2.32e-04	197	187	8	5285_UP
Drug	Debrisoquin sulfate [581-88-4]; Down 200; 9uM; MCF7; HT_HG-U133A	MAP4 KDM5A SPTLC2 TOM1 NR3C1 DOCK5 ZCCHC14 SMG7	2.32e-04	197	187	8	3207_DN
Drug	Isoniazid [54-85-3]; Up 200; 29.2uM; PC3; HT_HG-U133A	ABCA1 IFT74 NEB GTF3C5 L3MBTL1 HNRNPUL2 FKBP8 ATP2B3	2.32e-04	197	187	8	5840_UP
Drug	Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; PC3; HT_HG-U133A	DNAH3 SCRN3 MYO6 STEAP4 ATP13A2 ITPR2 SUGP2 SUPT6H	2.40e-04	198	187	8	5807_DN
Drug	Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A	SCRN3 MAP7D3 MAP4 KDM5A NF1 FAM169A PHF14 FKBP8	2.40e-04	198	187	8	2898_DN
Drug	Pheniramine maleate [132-20-7]; Up 200; 11.2uM; PC3; HG-U133A	MAP4 ZNF318 FHOD1 VPS13A TAF1 MTREX CNOT1 SEZ6L	2.40e-04	198	187	8	1910_UP
Drug	Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A	TDRKH TOM1 CUL9 ZNF318 DOCK5 NF1 VASH2 FKBP8	2.40e-04	198	187	8	6472_DN
Drug	Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; PC3; HT_HG-U133A	ABCA1 ACADSB IDH2 GTF3C5 ZCCHC14 CCDC88C VCAN VCL	2.40e-04	198	187	8	4654_DN
Drug	Loracarbef [121961-22-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A	ABCA1 SCRN3 SFTPC ZDHHC14 STEAP4 PRKD1 DMD ALK	2.40e-04	198	187	8	5492_UP
Drug	Sulfadiazine [68-35-9]; Up 200; 16uM; MCF7; HT_HG-U133A	TANC2 SLC9A8 SPTLC2 DOCK5 NF1 VASH2 ATP2B4 AHNAK2	2.40e-04	198	187	8	1688_UP
Drug	Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A	TDRKH ZNF318 DOCK5 DES RIF1 VCAN ATP2B4 AHNAK2	2.40e-04	198	187	8	1544_UP
Drug	Moricizine hydrochloride [31883-05-3]; Down 200; 8.6uM; MCF7; HT_HG-U133A	TDRKH IFT74 DOCK5 RIF1 NF1 HNRNPUL2 FKBP8 ATP2B4	2.40e-04	198	187	8	3520_DN
Drug	Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A	TMEM222 ATP13A2 NF1 SUGP2 ZNF592 PEX19 ALAD HERC4	2.40e-04	198	187	8	5537_DN
Drug	Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A	DNAH3 MAP4 SPTLC2 ZNF318 IDH2 GTF3C5 CCDC88C SMG7	2.40e-04	198	187	8	3434_DN
Drug	Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A	ANK3 MAP4 GTF3C5 STC1 PITX1 PEX19 HS3ST3A1 ATP2B4	2.40e-04	198	187	8	5467_DN
Drug	Monocrotaline [315-22-0]; Up 200; 12.2uM; PC3; HT_HG-U133A	IFT74 SPTBN2 DOCK5 DES SMG7 VCAN ALAD TAF1	2.40e-04	198	187	8	7127_UP
Drug	Nicardipine hydrochloride [54527-84-3]; Down 200; 7.8uM; PC3; HT_HG-U133A	SCRN3 MAP4 IFT74 SUGP2 SUPT6H VCAN VASH2 FAM169A	2.40e-04	198	187	8	6297_DN
Drug	Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; PC3; HT_HG-U133A	TANC2 KDM5A IFT74 IDH2 L3MBTL1 VASH2 MAP3K9 HERC4	2.40e-04	198	187	8	4479_DN
Drug	estradiol, USP; Down 200; 0.1uM; PC3; HT_HG-U133A	TDRKH IFT74 HNRNPUL2 PITX1 VASH2 PHF14 HERC4 VCL	2.40e-04	198	187	8	4432_DN
Drug	Dacarbazine [4342-03-4]; Up 200; 22uM; MCF7; HT_HG-U133A	SLC9A8 MAP4 ZCCHC14 DES PHF14 FKBP8 HS3ST3A1 VCL	2.40e-04	198	187	8	2754_UP
Drug	Famotidine [76824-35-6]; Down 200; 11.8uM; PC3; HT_HG-U133A	SLC9A8 ACADSB SPTLC2 TOM1 NEB SHROOM2 SMG7 VCAN	2.49e-04	199	187	8	6665_DN
Disease	age of onset of depressive disorder, wellbeing measurement	PTPDC1 KIRREL3 ANKFN1	2.51e-05	10	178	3	EFO_0007869, OBA_2040166
Disease	cleft lip	TANC2 ZNF536 MUC16 CCDC168 ZNF318 DST DMRT2 GVINP1 ANKFN1	6.10e-05	284	178	9	EFO_0003959
Disease	psychotic symptoms	ANK3 TSHZ2 WDFY4 DNAAF3 ST18	8.69e-05	74	178	5	EFO_0005940
Disease	Metastatic melanoma	ALPK3 MAP3K9 PRKD1 TAF1	3.20e-04	54	178	4	C0278883
Disease	hereditary sensory neuropathy (implicated_via_orthology)	SCN11A DST	3.58e-04	5	178	2	DOID:0050548 (implicated_via_orthology)
Disease	airway responsiveness measurement	USP24 WDFY4 ANKFN1	3.98e-04	24	178	3	EFO_0006897
Disease	triacylglycerol 58:7 measurement	ITSN1 PNPLA3 SEZ6L	3.98e-04	24	178	3	EFO_0010441
Disease	atrial fibrillation	SOX5 POLR2A LRRC10 NR3C1 RXRG ITPR2 ZFHX4 PITX1 CCDC136	4.46e-04	371	178	9	EFO_0000275
Disease	triacylglycerol 56:5 measurement	DOCK5 PNPLA3 ALK	5.07e-04	26	178	3	EFO_0010432
Disease	renal agenesis, unilateral	KDM5A TSHZ2 POLR1G TXNDC15	5.11e-04	61	178	4	MONDO_0019636
Disease	clubfoot (implicated_via_orthology)	PITX1 FKBP8	5.34e-04	6	178	2	DOID:11836 (implicated_via_orthology)
Disease	Hailey-Hailey disease (implicated_via_orthology)	ATP2B3 ATP2B4	5.34e-04	6	178	2	DOID:0050429 (implicated_via_orthology)
Disease	triglyceride measurement, intermediate density lipoprotein measurement	ABCA1 SHROOM3 BPTF CELSR2 PNPLA3	5.78e-04	111	178	5	EFO_0004530, EFO_0008595
Disease	mortality	SOX5 PSMC1 VPS13A PHF14 DMD HS3ST3B1	6.58e-04	173	178	6	EFO_0004352
Disease	stem Cell Factor measurement	ABCA1 MYO6 GTF3C5 AHNAK2	7.30e-04	67	178	4	EFO_0008291
Disease	X-23641 measurement	ACADSB PNPLA3	7.45e-04	7	178	2	EFO_0800854
Disease	heart failure	HECTD4 BPTF CELSR2 ZNF592 PRKD1 CCDC136	9.33e-04	185	178	6	EFO_0003144
Disease	stanniocalcin-1 measurement	STC1 CELSR2	9.89e-04	8	178	2	EFO_0020753
Disease	xerostomia	SHROOM3 EGFLAM	9.89e-04	8	178	2	EFO_0009869
Disease	mean corpuscular hemoglobin concentration	SOX5 ITSN1 POLR2A HECTD4 MYNN ZNF318 NEB ITPR2 RIF1 CTCF KIAA1217 VPS13A PNPLA3 FKBP8 CLSPN ATP2B4	1.12e-03	1105	178	16	EFO_0004528
Disease	peripheral arterial disease, traffic air pollution measurement	TANC2 ABCA1 ITPR2 MCTP1 HPCAL1 PRKD1	1.19e-03	194	178	6	EFO_0004265, EFO_0007908
Disease	cortical thickness	SOX5 ZNF536 SHROOM3 DDAH1 SPTBN2 CUL9 ZNF318 GLOD4 ATP13A2 DNAAF3 SMG7 SNAP91 VCAN PAM ANKFN1 ST18	1.21e-03	1113	178	16	EFO_0004840
Disease	uric acid measurement	SOX5 DNAH3 ABCA1 SHROOM3 SWT1 HECTD4 ZNF318 STC1 PTPDC1 PNPLA3 HERC4	1.26e-03	610	178	11	EFO_0004761
Disease	angiotensin-converting enzyme measurement	TANC2 KIRREL3	1.27e-03	9	178	2	EFO_0006515
Disease	cortical surface area measurement	TANC2 SOX5 ZNF536 SLC9A8 SHROOM3 DDAH1 ANK3 CUL9 ATP13A2 SLC38A2 CCDC88C DNAAF3 DMRT2 VCAN PAM PRKD1 HS3ST3B1 ANKFN1	1.35e-03	1345	178	18	EFO_0010736
Disease	urate measurement, bone density	KATNAL2 TSHZ2 ZDHHC14 KATNAL1 DNAH14 ITPR2 DOCK5 FSIP2 KIRREL3 HPCAL1 ATP2B4	1.41e-03	619	178	11	EFO_0003923, EFO_0004531
Disease	hypothyroidism (biomarker_via_orthology)	PAM PNPLA3 ALAD SERPINA7	1.42e-03	80	178	4	DOID:1459 (biomarker_via_orthology)
Disease	Intellectual Disability	TANC2 MAP7D3 KDM5A BPTF POLR3B NF1 CTCF TAF1 USP27X	1.65e-03	447	178	9	C3714756
Disease	diet measurement	SOX5 KATNAL2 ZNF536 ANK3 ACTN3 POLR1G DNAH14 KIRREL3 DST NF1 CELSR2 KIAA1217 NRG3 HS3ST3B1 CNOT1	1.81e-03	1049	178	15	EFO_0008111
Disease	testosterone measurement	SOX5 ZNF536 SHROOM3 ANK3 TSHZ2 POLR2A AKNA ZNF318 NR3C1 POLR1G DOCK5 TXNDC15 NF1 ZFHX4 PNPLA3 HERC4 ATP2B4	1.91e-03	1275	178	17	EFO_0004908
Disease	NG-monomethyl-arginine measurement	DDAH1 ANKFN1	1.92e-03	11	178	2	EFO_0010510
Disease	interleukin 1 receptor-like 1 measurement	IL18R1 KIRREL3	1.92e-03	11	178	2	EFO_0008168
Disease	forced expiratory volume, body mass index	DIS3L2 HECTD4	1.92e-03	11	178	2	EFO_0004314, EFO_0004340
Disease	free androgen index	SOX5 AKNA ZNF318 NR3C1 DOCK5 ZFHX4 PNPLA3 ATP2B4	2.04e-03	374	178	8	EFO_0007005
Disease	dilated cardiomyopathy (is_implicated_in)	DES DMD VCL	2.23e-03	43	178	3	DOID:12930 (is_implicated_in)
Disease	Mitral valve prolapse, response to surgery	ZNF592 ALPK3	2.30e-03	12	178	2	EFO_0009951, HP_0001634
Disease	Familial dilated cardiomyopathy	DES DMD VCL	2.38e-03	44	178	3	C0340427
Disease	trimethylamine-N-oxide measurement	ITPR2 ST18	3.14e-03	14	178	2	EFO_0010541
Disease	gamma-glutamylglutamate measurement	ZNF318 PRKD1	3.14e-03	14	178	2	EFO_0021137
Disease	early cardiac repolarization measurement	SLC9A8 PAM	3.14e-03	14	178	2	EFO_0004885
Disease	coronary artery disease (is_implicated_in)	ABCA1 DDAH1 NR3C1 PNPLA3	3.20e-03	100	178	4	DOID:3393 (is_implicated_in)
Disease	status epilepticus (biomarker_via_orthology)	ANK3 NR3C1 ALAD DMD	3.20e-03	100	178	4	DOID:1824 (biomarker_via_orthology)
Disease	antibody measurement	ZNF536 STING1 NEK5	3.24e-03	49	178	3	EFO_0004556
Disease	age at menarche	SOX5 MYO6 POLR1G RXRG KIRREL3 DST ZFHX4 SNAP91 PRKD1 ST18	3.39e-03	594	178	10	EFO_0004703
Disease	Hypertriglyceridemia	CELSR2 LIPI	3.61e-03	15	178	2	C0020557
Disease	autism spectrum disorder, schizophrenia	ZNF536 ZNF318 SNAP91 ZNF592 ALPK3 CNOT1 ATP2B4	3.83e-03	327	178	7	EFO_0003756, MONDO_0005090
Disease	pro-hydroxy-pro measurement	MCTP1 ALK	4.11e-03	16	178	2	EFO_0021132
Disease	triiodothyronine measurement	HS3ST3B1 SERPINA7	4.11e-03	16	178	2	EFO_0008392
Disease	response to acetylsalicylate	MAP4 DNAAF3	4.11e-03	16	178	2	GO_1903492
Disease	hair morphology measurement	KIRREL3 MCTP1 NRG3	4.27e-03	54	178	3	EFO_0007821
Disease	left ventricular diastolic function measurement	MCTP1 PHF14 VCL	4.27e-03	54	178	3	EFO_0008204
Disease	hip circumference	KIRREL3 NF1 EFCAB12 PRKD1 NRG3 HS3ST3B1 ATP2B4	4.58e-03	338	178	7	EFO_0005093
Disease	response to citalopram, antidepressant-induced dizziness, response to buspirone, response to antidepressant	ZDHHC14 DMD	4.64e-03	17	178	2	EFO_0006321, EFO_0006329, EFO_0006330, GO_0036276
Disease	Moyamoya Disease	RNF213 NF1	4.64e-03	17	178	2	C0026654
Disease	lysophosphatidylcholine 18:1 measurement	NRG3 ST18	4.64e-03	17	178	2	EFO_0010360
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	CELSR2 PNPLA3	4.64e-03	17	178	2	EFO_0022232
Disease	triglycerides in LDL measurement	ABCA1 BPTF CELSR2	4.73e-03	56	178	3	EFO_0022320
Disease	Hypertrophic Cardiomyopathy	IDH2 ALPK3 VCL	4.97e-03	57	178	3	C0007194
Disease	electrocardiography	SOX5 RXRG DNAAF3 DES ZNF592 PAM CNOT1 CCDC136 VCL	5.06e-03	530	178	9	EFO_0004327
Disease	sphingosine 1-phosphate measurement	DNAAF3 DMD	5.20e-03	18	178	2	EFO_0800185
Disease	low density lipoprotein particle size measurement	ABCA1 CELSR2 PNPLA3	5.22e-03	58	178	3	EFO_0008593
Disease	Malignant neoplasm of breast	ZNF318 SHROOM2 RXRB ZCCHC14 DES RIF1 TXNDC15 NF1 MROH7 AP1M1 FGD5 DMD CLSPN ALK	5.75e-03	1074	178	14	C0006142
Disease	severe acute respiratory syndrome, COVID-19	SOX5 WDFY4 DNAAF3 KIRREL3 KIAA1217 PHF14 DMD FAM9C	5.96e-03	447	178	8	EFO_0000694, MONDO_0100096
Disease	coronary artery disease	TDRKH ABCA1 SLC9A8 SHROOM3 MAP7D3 HECTD4 RNF213 DOCK5 DNAAF3 CELSR2 KIAA1217 PNPLA3 FGD5 ALK SEZ6L	6.00e-03	1194	178	15	EFO_0001645

Protein segments in the cluster

Peptide	Gene	Start	Entry
METDLAEMPEKGALS	ZNF286A	1	Q9HBT8
IQMDSMVIKGLDPDT	EGFLAM	196	Q63HQ2
KVPSMIIAMTDGELV	ANTXRL	171	A6NF34
HPIAKEETVMMEGSG	VCAN	1946	P13611
LDPTLLQMKTEVMEG	CTCF	66	P49711
LQMKTEVMEGTVAPE	CTCF	71	P49711
IVKLGREEPAMSMDA	COPB2	296	P35606
REEPAMSMDANGKII	COPB2	301	P35606
AADLMISGVPIELMD	GVINP1	1441	Q7Z2Y8
EMEQMALDVGLPSSK	ABCA1	1011	O95477
MAESFKELDPDSSMG	SH3BP1	81	Q9Y3L3
KELDPDSSMGKALEM	SH3BP1	86	Q9Y3L3
EEIEMTPMVFAKGLA	ALPK3	1581	Q96L96
ILMEKEEEGMLSPIL	AP1M1	36	Q9BXS5
AGLFMKIEPMRETSL	BRPF3	356	Q9ULD4
IAPLVSTMDENSKME	ACADSB	76	P45954
LMMSVDTVIPAGEKV	PAM	201	P19021
MTDGILGKAATMEIP	ARFIP2	1	P53365
GADGVMRTMAPEKLL	SNAP91	151	O60641
PTISLAGASMMEIKE	CFAP92	306	Q9ULG3
MPIAMSIKAGTVDED	CELSR2	2896	Q9HCU4
DMELTKRSAVEGMPS	DMD	1591	P11532
EMLETIPEEAGITMS	AMPD2	861	Q01433
LVKESGPLESEAMVM	DIS3L2	761	Q8IYB7
GVIKEPMDLATMEER	BPTF	2966	Q12830
ETRPMTLEEMEEVGK	EFCAB12	321	Q6NXP0
DKDPMLLSGTHVMEG	ATP2B3	256	Q16720
MQPLKSAEGGEMEER	ATP2B3	331	Q16720
DKDPMLLSGTHVMEG	ATP2B4	251	P23634
APGKDSREMMQLASE	MROH7	711	Q68CQ1
PHERATMDDMGLVAK	PPP2R3B	156	Q9Y5P8
KEVIEREAPGMALAM	GPHN	101	Q9NQX3
KRDDDNELMTSGPRM	ITPR2	1836	Q14571
PVTALEKMMESSFVG	NRG3	436	P56975
PKVTGSMMEDAIVST	MUC16	6041	Q8WXI7
KAGALLMDLETPEEM	C19orf81	21	C9J6K1
GSDPNIHEEKEMRIM	IL18R1	256	Q13478
MLEMILSSEKGRLPE	PRKD1	666	Q15139
DLMPRTLDGQITMEK	HS3ST3B1	186	Q9Y662
LTPKEGESRDVTMLM	MCTP1	381	Q6DN14
MSPLSETEMALGKDV	MAP4	506	P27816
MADTIEEGTMPKEMS	GNAT1	106	P11488
EEGTMPKEMSDIIQR	GNAT1	111	P11488
IGDRDGVMPKMDIIS	ALAS1	426	P13196
KMDPEGSKLLDDAMA	GLOD4	281	Q9HC38
APSDMMDGRVEAIKE	ALAD	166	P13716
KMMLATEETSPDLVG	DST	5236	Q03001
DDMKLSEIDFPMARS	KIAA2026	896	Q5HYC2
MIGRDPLSGKSMEEI	CCDC88C	106	Q9P219
ELDMATPKTMPETAS	FSIP2	6751	Q5CZC0
GMKLEAVDRMNPSLV	L3MBTL1	416	Q9Y468
ELDAMMKEASGPINF	MYLPF	66	Q96A32
KPLSAFIGMNSEMRE	KATNAL2	221	Q8IYT4
RKDGKPFDEMDETLM	PDE6A	406	P16499
MDIPNETLTFEDGMK	NEK5	601	Q6P3R8
GLKSSSEGMDPEVAM	PNPLA3	261	Q9NST1
MDMASDILQPKGDDV	ECH1	121	Q13011
MASEDKVALESMPLL	FGD5	1396	Q6ZNL6
LDDLKELMPDVGRSM	HERC4	831	Q5GLZ8
MKMPEDESTPEKRTD	HPCAL1	136	P37235
GDDVPESIMLEMKAN	HNRNPUL2	581	Q1KMD3
ETMDVKPSDMTLPLA	MYNN	551	Q9NPC7
LDKTMSIEFPEMLAE	NR3C1	741	P04150
DLMPRTLDGQITMEK	HS3ST3A1	201	Q9Y663
REMPLDKMVDLSGSQ	LRRC10	26	Q5BKY1
SGLPRTMTQKDVEDM	ELAVL1	111	Q15717
MMKDVSEGPGLSAEI	PTPDC1	306	A2A3K4
PAGSSVLKVMAIDMD	PCDHGB3	256	Q9Y5G1
DVVDGKTPMSAEMRE	PANX1	376	Q96RD7
MSAPSDLEMIGNEDL	HECTD4	1106	Q9Y4D8
SLDPESIFEMMETGK	EXOSC7	246	Q15024
MGPEEKTIMTERSAA	IQCF5	1	A8MTL0
ADMAMETLPDGTKRS	PHF14	786	O94880
DETPDSSKLQMLIDM	KDM5A	866	P29375
MPSEREVGTEAKMLL	PAAF1	241	Q9BRP4
AGPVIMSIEEKMEAD	PABPN1	156	Q86U42
SSMSEEELTKAMEGL	PEX19	146	P40855
METDLAEMPEKGVLS	FOXO3B	1	A0A2Z4LIS9
DTPVGDPMDLKMVES	ATP13A2	566	Q9NQ11
LDLSVPLMDVGETAM	FKBP8	156	Q14318
TGRMLKMEPLATVES	HECTD1	1016	Q9ULT8
VDLKPSGEDEMITMD	HECTD1	2426	Q9ULT8
VAKPVVEMDGDEMTR	IDH2	46	P48735
MIAEDKSIGSPMEER	IFT74	291	Q96LB3
LTLPGTKMEMEEKEL	DOCK5	586	Q9H7D0
MLIFSLALEEPEKMG	DNAAF3	91	Q8N9W5
GLSAEQDMMPSKLEG	DMRT2	386	Q9Y5R5
MIAPEEGEVMVRISK	DNAH3	246	Q8TD57
SDMAEVKSMFREVLP	BBIP1	21	A8MTZ0
PLMESELLTEKEVAM	ITSN1	1266	Q15811
VEMDMSKPDLTAALR	DES	261	P17661
LSVKSLPEAMRMEEE	AKNA	766	Q7Z591
MSDDEVRKANAPEML	ANK3	846	Q12955
ARDSMMIEELLVPSK	ANK3	931	Q12955
MTAEKGPMIVLVLDE	CDC6	271	Q99741
EEIAVGTPSTLKSMM	DNAH14	3156	Q0VDD8
DGLMKREETPRTMTE	DRC7	536	Q8IY82
PMNGEIMDDSLKTSL	FAM169A	426	Q9Y6X4
RIPDSEMLMDEGTSD	FAM169A	491	Q9Y6X4
VVFKGLMSDPMTDLD	IFFO2	266	Q5TF58
LMSDPMTDLDTKIQE	IFFO2	271	Q5TF58
ESMEASPEAMVKASP	MAP7D3	436	Q8IWC1
DHTGPKFDIDMMVSL	MALSU1	86	Q96EH3
MKSGAGLEAESVPMA	KIRREL3	521	Q8IZU9
LVTEGMTLPTEMKEA	CUL9	646	Q8IWT3
PTMDATKMGGLEEDT	CCDC168	5701	Q8NDH2
DGIEKLLTMMPTEEE	FHOD1	731	Q9Y613
VMAAQEMELAGKDPV	FAM9C	11	Q8IZT9
PMDMSLDKAEAALVA	CLIP3	241	Q96DZ5
DTERMLAKSAMPIEV	CSTF1	136	Q05048
VIMFDVDSKDPTLGM	METTL13	571	Q8N6R0
MDPMTVRKEDLGSLG	GPRIN1	201	Q7Z2K8
KADPMPLESMDSAST	GPRIN1	296	Q7Z2K8
MLIPVSMSELEKVDG	DDAH1	256	O94760
LPGFTSLMEMEDEDS	MAP3K9	666	P80192
DMPEAELLLMVAGEV	DIPK1C	141	Q0P6D2
MDVGSKEVLMESPPD	SFTPC	1	P11686
MDAFKGGMSLERLPE	PITX1	1	P78337
LTSEMLMLSPGSEED	SYT7	111	O43581
GALENDDPSKMVMVL	KATNAL1	341	Q9BW62
MDEERSSMLPTMAAG	SNX29P2	1	Q8IUI4
TMSQEPELLISGMEK	STING1	356	Q86WV6
MTKMDIRGAVDAAVP	ATP6V1H	1	Q9UI12
DTSPMALMDKGENEL	SEZ6L	236	Q9BYH1
AETPGMEESLAEMSI	SPAG5	961	Q96R06
SPNITMATRKELEEM	PPP4R1	496	Q8TF05
PDTGEKMILIGRMSA	SFXN1	81	Q9H9B4
LSIIVPDKTMMDGSF	LIPI	341	Q6XZB0
MVVSAGPLSSEKAEM	NBPF15	1	Q8N660
LPGLETVEMMEESSG	RIF1	966	Q5UIP0
LSDDEITMMAPVESK	TAF1	306	P21675
FETMMEILRDKPSGI	SCRN3	256	Q0VDG4
PSMEDSSAVLMESLK	SMG7	1086	Q92540
ALEVDMALGSPEMDV	POLR1G	196	O15446
DAKSEVVPLSGMMVR	KIAA1217	871	Q5T5P2
KTTMDLMEGIFPKDE	SHROOM2	1341	Q13796
LDPDSRLKTTMDLME	SHROOM3	1686	Q8TF72
STMPLIRLMDIEDAK	SLC9A8	466	Q9Y2E8
ADKQGRTPLMMAASE	TANC2	1096	Q9HCD6
GVLMDDTDPLVTVMK	PSMC1	161	P62191
KSVDLPGELMSMEID	SWT1	356	Q5T5J6
PVEMVKDISDGATVM	OXCT2	46	Q9BYC2
VAEMMLALGPKEVRE	EARS2	501	Q5JPH6
KLIGDTPIDTFLMEM	RXRB	511	P28702
TAEEIMIKPMDESLL	ST18	91	O60284
STIRDSLMEKIGPNM	STC1	176	P52823
MQTLAPEVKTMTRDG	SUPT20HL2	171	P0C7V6
MDLLDGPGAERSKEM	ALK	301	Q9UM73
LKVEADMSLPSMQGD	AHNAK2	2676	Q8IVF2
GEPSMSAMQRKLEDF	ACTN3	316	Q08043
IASLRAEMEMKSSEP	CCDC136	196	Q96JN2
MSEDFSPLAGEIIMD	ANKFN1	311	Q8N957
KESSMGDPMEEALAL	CLSPN	966	Q9HAW4
MDRILPDSGGVAKTM	CNOT1	236	A5YKK6
MSIAGDATPLLDEMD	SUPT6H	1711	Q7KZ85
MEEVVSEFEPGMATK	SPATA31A3	1006	Q5VYP0
MELSALRSDTEPGMD	RNF213	2141	Q63HN8
MRSELLGTDSAEPEM	USE1	121	Q9NZ43
GDKLLEPVVSMSDML	VPS4B	401	O75351
QSMSEEEREKVTPLM	SEPHS2	181	Q99611
SGESPMDDKSMAGLE	ZFHX4	1276	Q86UP3
LELDMTPFMASSKES	USP27X	331	A6NNY8
KIEGLDSEMIMRPSE	VPS13A	1076	Q96RL7
ENRAVPDMLKDMATE	TDRKH	501	Q9Y2W6
PDMLKDMATETDASL	TDRKH	506	Q9Y2W6
DRGIVILMVDEKMSP	MTREX	531	P42285
ERLPMASSMEHGKDL	SPTBN2	1506	O15020
DPEDVDVMMGTFTKS	SPTLC2	366	O15270
MKKAEMGRFSISPDE	SLC38A2	1	Q96QD8
RKGLEFPMTDLDMLS	TOM1	146	O60784
GESDPMKGVSENIML	POLR2A	1446	P24928
MGDMKTPDFDDLLAA	ZNF592	1	Q92610
PSADIDMKTMETAEK	SUGP2	776	Q8IX01
LPKEGQMESVEAAMS	SERPINA7	271	P05543
MVMLSVIPGEAEDKV	TXNDC15	91	Q96J42
ASDELSKTISPMVMD	VCL	786	P18206
TELMDGPKDSLDAML	WDFY4	1731	Q6ZS81
GQPKDTMRLDETMLV	NF1	96	P21359
KLIGDTPIDTFLMEM	RXRG	441	P48443
TPMDQGSLMAAKEIE	STEAP4	176	Q687X5
GLMETAKEMTRESLP	VASH2	141	Q86V25
TFDKVMGPMLDAATR	POLR3B	786	Q9NW08
MSITGSLDMALPEKD	SGSM1	851	Q2NKQ1
ASSSRVPPMKLEMDV	TSHZ2	811	Q9NRE2
ATLADVMPRKDEHMG	ZDHHC14	421	Q8IZN3
EDVETEPEMMTKPLS	ZNF536	1181	O15090
IMGKMEADPELSKFL	SNRNP200	346	O75643
MAEVEAPTAAETDMK	TMEM222	21	Q9H0R3
VDKSFGSAMMDVLPA	ZCCHC14	551	Q8WYQ9
LSSKLMPTADDDMAR	USP24	1181	Q9UPU5
MGDMKTPDFDDLLAA	ZNF687	1	Q8N1G0
IPLVMEMKRGSETQE	SCN11A	881	Q9UI33
SMEEMIPLDSAKESL	ZBED9	151	Q6R2W3
TPESLAEKERQLMGM	SOX5	191	P35711
PKTSDELRDTMSLMI	GTF3C5	441	Q9Y5Q8
METDLAEMPEKGVLS	ZNF286B	1	P0CG31
LTMELTGDSMEVKPI	SUDS3	166	Q9H7L9
AGGMMPEEVKESSQL	ZNF318	2131	Q5VUA4
PLRESALMDISDMVK	TSHZ1	831	Q6ZSZ6
PDLMDRGTEKSVMNV	MX2	296	P20592
TFISETGKIEPDMMG	NACC1	491	Q96RE7
EQMAKEMSEFLSRGP	MYO6	1056	Q9UM54
GLTEMEDTPDMLRAK	NEB	5986	P20929